SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2b39'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EPB_A_9CRA165_2
(EPIDIDYMAL RETINOIC
ACID-BINDING PROTEIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ALA A 109
PHE A 111
VAL A  57
VAL A  55
 None
 0.85A 1epbA-2b39A:
undetectable		 1epbA-2b39A:
7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FE2_A_LAXA700_1
(PROSTAGLANDIN
ENDOPEROXIDE H
SYNTHASE-1)		 2b39 C3
(Bos
taurus) 		5 / 10 ARG A1049
PHE A 221
VAL A 223
VAL A 144
ASN A 199
 None
 1.17A 1fe2A-2b39A:
undetectable		 1fe2A-2b39A:
15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTB_A_PZQA901_0
(GLUTATHIONE
S-TRANSFERASE)		 2b39 C3
(Bos
taurus) 		3 / 3 GLN A 482
TYR A 488
ARG A 503
 None
 0.95A 1gtbA-2b39A:
3.0		 1gtbA-2b39A:
8.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2R_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 1k2rA-2b39A:
undetectable
1k2rB-2b39A:
undetectable		 1k2rA-2b39A:
13.47
1k2rB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2R_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 1k2rA-2b39A:
undetectable
1k2rB-2b39A:
undetectable		 1k2rA-2b39A:
13.47
1k2rB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2S_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.02A 1k2sA-2b39A:
undetectable
1k2sB-2b39A:
undetectable		 1k2sA-2b39A:
13.47
1k2sB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2T_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 1k2tA-2b39A:
2.4
1k2tB-2b39A:
undetectable		 1k2tA-2b39A:
13.47
1k2tB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2T_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 1k2tA-2b39A:
2.4
1k2tB-2b39A:
undetectable		 1k2tA-2b39A:
13.47
1k2tB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2U_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.02A 1k2uA-2b39A:
undetectable
1k2uB-2b39A:
undetectable		 1k2uA-2b39A:
13.47
1k2uB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2U_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 1k2uA-2b39A:
undetectable
1k2uB-2b39A:
undetectable		 1k2uA-2b39A:
13.47
1k2uB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZX_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 1lzxA-2b39A:
2.4
1lzxB-2b39A:
undetectable		 1lzxA-2b39A:
13.47
1lzxB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZX_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 1lzxA-2b39A:
2.4
1lzxB-2b39A:
undetectable		 1lzxA-2b39A:
13.47
1lzxB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZZ_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 1lzzA-2b39A:
undetectable
1lzzB-2b39A:
undetectable		 1lzzA-2b39A:
13.47
1lzzB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZZ_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 1lzzA-2b39A:
undetectable
1lzzB-2b39A:
undetectable		 1lzzA-2b39A:
13.47
1lzzB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M00_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 1m00A-2b39A:
undetectable
1m00B-2b39A:
undetectable		 1m00A-2b39A:
13.47
1m00B-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M00_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 1m00A-2b39A:
undetectable
1m00B-2b39A:
undetectable		 1m00A-2b39A:
13.47
1m00B-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMV_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 1mmvA-2b39A:
undetectable
1mmvB-2b39A:
undetectable		 1mmvA-2b39A:
13.47
1mmvB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMV_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 1mmvA-2b39A:
undetectable
1mmvB-2b39A:
undetectable		 1mmvA-2b39A:
13.47
1mmvB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMW_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 1mmwA-2b39A:
undetectable
1mmwB-2b39A:
2.4		 1mmwA-2b39A:
13.47
1mmwB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMW_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 1mmwA-2b39A:
undetectable
1mmwB-2b39A:
2.4		 1mmwA-2b39A:
13.47
1mmwB-2b39A:
13.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NSI_B_H4BB601_1
(PROTEIN (NITRIC
OXIDE SYNTHASE))		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A1650
GLU A1652
ARG A1530
ILE A1567
 None
 1.48A 1nsiA-2b39A:
undetectable
1nsiB-2b39A:
undetectable		 1nsiA-2b39A:
13.65
1nsiB-2b39A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NSI_D_H4BD603_1
(PROTEIN (NITRIC
OXIDE SYNTHASE))		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A1650
GLU A1652
ARG A1530
ILE A1567
 None
 1.48A 1nsiC-2b39A:
undetectable
1nsiD-2b39A:
undetectable		 1nsiC-2b39A:
13.65
1nsiD-2b39A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM4_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.04A 1om4A-2b39A:
undetectable
1om4B-2b39A:
undetectable		 1om4A-2b39A:
13.58
1om4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM4_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 1om4A-2b39A:
undetectable
1om4B-2b39A:
undetectable		 1om4A-2b39A:
13.58
1om4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM5_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 0.99A 1om5A-2b39A:
undetectable
1om5B-2b39A:
undetectable		 1om5A-2b39A:
13.53
1om5B-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM5_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.01A 1om5A-2b39A:
undetectable
1om5B-2b39A:
undetectable		 1om5A-2b39A:
13.53
1om5B-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P33_A_MTXA351_1
(PTERIDINE REDUCTASE
1)		 2b39 C3
(Bos
taurus) 		5 / 12 SER A1382
LEU A1442
PRO A1412
MET A1433
TYR A1431
 None
 1.50A 1p33A-2b39A:
undetectable		 1p33A-2b39A:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6H_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 1p6hA-2b39A:
undetectable
1p6hB-2b39A:
undetectable		 1p6hA-2b39A:
13.53
1p6hB-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6H_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 1p6hA-2b39A:
undetectable
1p6hB-2b39A:
undetectable		 1p6hA-2b39A:
13.53
1p6hB-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6I_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 1p6iA-2b39A:
undetectable
1p6iB-2b39A:
undetectable		 1p6iA-2b39A:
13.53
1p6iB-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6I_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 1p6iA-2b39A:
undetectable
1p6iB-2b39A:
undetectable		 1p6iA-2b39A:
13.53
1p6iB-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6J_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 1p6jA-2b39A:
undetectable
1p6jB-2b39A:
undetectable		 1p6jA-2b39A:
13.53
1p6jB-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6J_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 1p6jA-2b39A:
undetectable
1p6jB-2b39A:
undetectable		 1p6jA-2b39A:
13.53
1p6jB-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 1p6kA-2b39A:
undetectable
1p6kB-2b39A:
undetectable		 1p6kA-2b39A:
13.59
1p6kB-2b39A:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 1p6kA-2b39A:
undetectable
1p6kB-2b39A:
undetectable		 1p6kA-2b39A:
13.59
1p6kB-2b39A:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QHY_A_CLMA999_0
(CHLORAMPHENICOL
PHOSPHOTRANSFERASE)		 2b39 C3
(Bos
taurus) 		5 / 12 VAL A 107
ILE A  88
ILE A  90
VAL A 120
LEU A  34
 None
 1.02A 1qhyA-2b39A:
undetectable		 1qhyA-2b39A:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 1rs6A-2b39A:
undetectable
1rs6B-2b39A:
2.4		 1rs6A-2b39A:
13.53
1rs6B-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 1rs6A-2b39A:
undetectable
1rs6B-2b39A:
2.4		 1rs6A-2b39A:
13.53
1rs6B-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS7_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 1rs7A-2b39A:
undetectable
1rs7B-2b39A:
undetectable		 1rs7A-2b39A:
13.53
1rs7B-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS7_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 1rs7A-2b39A:
undetectable
1rs7B-2b39A:
undetectable		 1rs7A-2b39A:
13.53
1rs7B-2b39A:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SG9_B_SAMB302_1
(HEMK PROTEIN)		 2b39 C3
(Bos
taurus) 		3 / 3 ASP A1403
PHE A1490
ASN A1438
 None
 0.85A 1sg9B-2b39A:
undetectable		 1sg9B-2b39A:
10.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T9W_A_NFNA6001_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)		 2b39 C3
(Bos
taurus) 		3 / 3 SER A1007
GLY A1008
ARG A1435
 None
 0.65A 1t9wA-2b39A:
3.7		 1t9wA-2b39A:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V8B_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 2b39 C3
(Bos
taurus) 		3 / 3 GLU A 262
GLU A 855
LEU A 859
 None
 0.56A 1v8bA-2b39A:
undetectable		 1v8bA-2b39A:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V8B_B_ADNB1502_2
(ADENOSYLHOMOCYSTEINA
SE)		 2b39 C3
(Bos
taurus) 		3 / 3 GLU A 262
GLU A 855
LEU A 859
 None
 0.52A 1v8bB-2b39A:
undetectable		 1v8bB-2b39A:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WG8_A_SAMA3142_0
(PREDICTED
S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE)		 2b39 C3
(Bos
taurus) 		5 / 12 THR A1340
GLY A 983
GLY A1337
GLN A 988
MET A 989
 None
 1.05A 1wg8A-2b39A:
undetectable		 1wg8A-2b39A:
10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WG8_B_SAMB3141_0
(PREDICTED
S-ADENOSYLMETHIONINE
-DEPENDENT
METHYLTRANSFERASE)		 2b39 C3
(Bos
taurus) 		5 / 12 THR A1340
GLY A 983
GLY A1337
GLN A 988
MET A 989
 None
 1.00A 1wg8B-2b39A:
undetectable		 1wg8B-2b39A:
10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XL6_B_SPMB3001_1
(INWARD RECTIFIER
POTASSIUM CHANNEL)		 2b39 C3
(Bos
taurus) 		4 / 5 ALA A1189
ALA A1238
TYR A1234
GLN A1269
 None
 1.12A 1xl6A-2b39A:
6.4
1xl6B-2b39A:
6.1		 1xl6A-2b39A:
10.64
1xl6B-2b39A:
10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZVL_A_H4BA900_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 1zvlA-2b39A:
undetectable
1zvlB-2b39A:
undetectable		 1zvlA-2b39A:
13.70
1zvlB-2b39A:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZVL_B_H4BB920_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 1zvlA-2b39A:
0.0
1zvlB-2b39A:
0.0		 1zvlA-2b39A:
13.70
1zvlB-2b39A:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZQ_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 1zzqA-2b39A:
undetectable
1zzqB-2b39A:
undetectable		 1zzqA-2b39A:
13.58
1zzqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZQ_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 1zzqA-2b39A:
undetectable
1zzqB-2b39A:
undetectable		 1zzqA-2b39A:
13.58
1zzqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 1zzrA-2b39A:
undetectable
1zzrB-2b39A:
undetectable		 1zzrA-2b39A:
13.68
1zzrB-2b39A:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 1zzrA-2b39A:
undetectable
1zzrB-2b39A:
undetectable		 1zzrA-2b39A:
13.68
1zzrB-2b39A:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 1zzuA-2b39A:
undetectable
1zzuB-2b39A:
2.3		 1zzuA-2b39A:
13.68
1zzuB-2b39A:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.10A 1zzuA-2b39A:
undetectable
1zzuB-2b39A:
2.3		 1zzuA-2b39A:
13.68
1zzuB-2b39A:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AZQ_A_PCFA954_0
(CATECHOL
1,2-DIOXYGENASE)		 2b39 C3
(Bos
taurus) 		5 / 9 LEU A1002
HIS A1025
ALA A1023
TYR A1026
LEU A1027
 None
 1.34A 2azqA-2b39A:
2.9		 2azqA-2b39A:
11.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BR4_D_SAMD301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 2b39 C3
(Bos
taurus) 		3 / 3 LYS A1110
ASP A 716
ASP A1120
 None
 1.01A 2br4D-2b39A:
undetectable		 2br4D-2b39A:
9.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIM_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.17A 2eimJ-2b39A:
undetectable		 2eimJ-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EIM_W_CHDW1060_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE
VIIA-HEART)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.17A 2eimW-2b39A:
undetectable		 2eimW-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6H_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 2g6hA-2b39A:
undetectable
2g6hB-2b39A:
undetectable		 2g6hA-2b39A:
13.52
2g6hB-2b39A:
13.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6H_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 2g6hA-2b39A:
undetectable
2g6hB-2b39A:
undetectable		 2g6hA-2b39A:
13.52
2g6hB-2b39A:
13.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6K_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.02A 2g6kA-2b39A:
undetectable
2g6kB-2b39A:
undetectable		 2g6kA-2b39A:
13.52
2g6kB-2b39A:
13.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6K_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 2g6kA-2b39A:
undetectable
2g6kB-2b39A:
undetectable		 2g6kA-2b39A:
13.52
2g6kB-2b39A:
13.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6M_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 2g6mA-2b39A:
undetectable
2g6mB-2b39A:
undetectable		 2g6mA-2b39A:
13.52
2g6mB-2b39A:
13.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6M_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 2g6mA-2b39A:
undetectable
2g6mB-2b39A:
undetectable		 2g6mA-2b39A:
13.52
2g6mB-2b39A:
13.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HX3_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 2hx3A-2b39A:
undetectable
2hx3B-2b39A:
undetectable		 2hx3A-2b39A:
13.58
2hx3B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HX3_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 2hx3A-2b39A:
0.0
2hx3B-2b39A:
0.0		 2hx3A-2b39A:
13.58
2hx3B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HX4_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 2hx4A-2b39A:
undetectable
2hx4B-2b39A:
undetectable		 2hx4A-2b39A:
13.58
2hx4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HX4_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 2hx4A-2b39A:
undetectable
2hx4B-2b39A:
undetectable		 2hx4A-2b39A:
13.58
2hx4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_B_TPFB2470_1
(CYTOCHROME P450 121)		 2b39 C3
(Bos
taurus) 		5 / 9 VAL A1251
MET A1273
PHE A1209
THR A1232
ALA A1189
 None
 1.50A 2ij7B-2b39A:
0.0		 2ij7B-2b39A:
12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_F_TPFF2474_1
(CYTOCHROME P450 121)		 2b39 C3
(Bos
taurus) 		5 / 10 VAL A1251
MET A1273
PHE A1209
THR A1232
ALA A1189
 None
 1.45A 2ij7F-2b39A:
0.0		 2ij7F-2b39A:
12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NSI_A_H4BA600_1
(PROTEIN (NITRIC
OXIDE SYNTHASE))		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A1530
ILE A1567
PHE A1650
GLU A1652
 None
 1.49A 2nsiA-2b39A:
undetectable
2nsiB-2b39A:
undetectable		 2nsiA-2b39A:
13.65
2nsiB-2b39A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NSI_B_H4BB601_1
(PROTEIN (NITRIC
OXIDE SYNTHASE))		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A1650
GLU A1652
ARG A1530
ILE A1567
 None
 1.49A 2nsiA-2b39A:
undetectable
2nsiB-2b39A:
undetectable		 2nsiA-2b39A:
13.65
2nsiB-2b39A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NSI_C_H4BC602_1
(PROTEIN (NITRIC
OXIDE SYNTHASE))		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A1530
ILE A1567
PHE A1650
GLU A1652
 None
 1.50A 2nsiC-2b39A:
undetectable
2nsiD-2b39A:
undetectable		 2nsiC-2b39A:
13.65
2nsiD-2b39A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PYM_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 2b39 C3
(Bos
taurus) 		3 / 3 ASP A1484
ASN A1482
THR A1268
 None
 0.73A 2pymB-2b39A:
undetectable		 2pymB-2b39A:
4.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 2b39 C3
(Bos
taurus) 		3 / 3 ASP A1484
ASN A1482
THR A1268
 None
 0.72A 2q63B-2b39A:
undetectable		 2q63B-2b39A:
4.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q83_A_ADNA1_1
(YTAA PROTEIN)		 2b39 C3
(Bos
taurus) 		4 / 7 CYH A1009
PRO A1006
ILE A1443
ILE A1401
 None
 0.88A 2q83A-2b39A:
undetectable		 2q83A-2b39A:
12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD5_B_CHDB1104_0
(FERROCHELATASE)		 2b39 C3
(Bos
taurus) 		3 / 3 LEU A 834
PRO A 835
LEU A 928
 None
 0.49A 2qd5B-2b39A:
undetectable		 2qd5B-2b39A:
12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R2V_D_ACTD36_0
(GCN4 LEUCINE ZIPPER)		 2b39 C3
(Bos
taurus) 		3 / 3 SER A1029
TYR A1026
HIS A1025
 None
 0.71A 2r2vD-2b39A:
undetectable		 2r2vD-2b39A:
3.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2RK8_A_PPFA3969_1
(PHOSPHOENOLPYRUVATE
CARBOXYKINASE,
CYTOSOLIC [GTP])		 2b39 C3
(Bos
taurus) 		4 / 8 HIS A1462
SER A1382
ASP A1413
ALA A1369
 None
 1.30A 2rk8A-2b39A:
undetectable		 2rk8A-2b39A:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3M_B_FOLB1188_0
(DIHYDROFOLATE
REDUCTASE)		 2b39 C3
(Bos
taurus) 		5 / 12 ILE A 281
LEU A 301
LEU A 318
TYR A 324
THR A 284
 None
 1.29A 2w3mB-2b39A:
undetectable		 2w3mB-2b39A:
8.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_B_EV1B1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)		 2b39 C3
(Bos
taurus) 		4 / 8 LEU A1601
VAL A1539
TYR A1618
PHE A1582
 None
 0.98A 2weyB-2b39A:
undetectable		 2weyB-2b39A:
11.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X7H_A_PFNA1374_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 2b39 C3
(Bos
taurus) 		4 / 6 PRO A1006
GLU A1011
TYR A1480
CYH A1009
 None
 1.37A 2x7hA-2b39A:
undetectable		 2x7hA-2b39A:
12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X7H_B_PFNB1374_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 2b39 C3
(Bos
taurus) 		4 / 4 TYR A 532
LEU A 650
LEU A 644
HIS A  47
 None
 1.50A 2x7hB-2b39A:
undetectable		 2x7hB-2b39A:
12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_D_DVAD8_0
(GRAMICIDIN A)		 2b39 C3
(Bos
taurus) 		3 / 3 TRP A1603
VAL A1605
TRP A1625
 None
 1.24A 2xdcC-2b39A:
undetectable
2xdcD-2b39A:
undetectable		 2xdcC-2b39A:
1.03
2xdcD-2b39A:
1.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XDC_F_DVAF8_0
(GRAMICIDIN A)		 2b39 C3
(Bos
taurus) 		3 / 3 TRP A1603
VAL A1605
TRP A1625
 None
 1.25A 2xdcE-2b39A:
undetectable
2xdcF-2b39A:
undetectable		 2xdcE-2b39A:
1.03
2xdcF-2b39A:
1.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y5M_F_DVAF8_0
(VAL-GRAMICIDIN A)		 2b39 C3
(Bos
taurus) 		3 / 3 TRP A1603
VAL A1605
TRP A1625
 None
 1.23A 2y5mE-2b39A:
undetectable
2y5mF-2b39A:
undetectable		 2y5mE-2b39A:
1.03
2y5mF-2b39A:
1.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y69_P_CHDP1265_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 3)		 2b39 C3
(Bos
taurus) 		4 / 5 PHE A 363
PHE A 369
LEU A 371
PHE A 356
 None
 1.24A 2y69P-2b39A:
undetectable
2y69W-2b39A:
undetectable		 2y69P-2b39A:
9.83
2y69W-2b39A:
4.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6N_D_DVAD8_0
(VAL-GRAMICIDIN A)		 2b39 C3
(Bos
taurus) 		3 / 3 TRP A1603
VAL A1605
TRP A1625
 None
 1.23A 2y6nC-2b39A:
undetectable
2y6nD-2b39A:
undetectable		 2y6nC-2b39A:
1.03
2y6nD-2b39A:
1.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6N_F_DVAF8_0
(VAL-GRAMICIDIN A)		 2b39 C3
(Bos
taurus) 		3 / 3 TRP A1603
VAL A1605
TRP A1625
 None
 1.23A 2y6nE-2b39A:
undetectable
2y6nF-2b39A:
undetectable		 2y6nE-2b39A:
1.03
2y6nF-2b39A:
1.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YFX_A_VGHA9000_1
(TYROSINE-PROTEIN
KINASE RECEPTOR)		 2b39 C3
(Bos
taurus) 		5 / 8 LEU A 561
ALA A 589
GLY A 559
GLY A 784
ASP A 781
 None
 1.35A 2yfxA-2b39A:
undetectable		 2yfxA-2b39A:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZTH_A_SAMA305_1
(CATECHOL
O-METHYLTRANSFERASE)		 2b39 C3
(Bos
taurus) 		3 / 3 SER A 797
GLU A 767
ASP A 597
 None
 0.79A 2zthA-2b39A:
undetectable		 2zthA-2b39A:
9.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZUJ_A_CAMA422_0
(CAMPHOR
5-MONOOXYGENASE)		 2b39 C3
(Bos
taurus) 		4 / 8 THR A1323
VAL A1343
LEU A1299
VAL A1331
 None
 0.76A 2zujA-2b39A:
undetectable		 2zujA-2b39A:
13.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A50_D_VD3D2001_1
(VITAMIN D
HYDROXYLASE)		 2b39 C3
(Bos
taurus) 		6 / 12 PRO A 700
ILE A1428
LEU A1420
LEU A1385
ILE A1387
LEU A1442
 None
 1.42A 3a50D-2b39A:
undetectable		 3a50D-2b39A:
12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG1_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.16A 3ag1J-2b39A:
undetectable		 3ag1J-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG1_W_CHDW1059_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1
CYTOCHROME C OXIDASE
SUBUNIT 1)		 2b39 C3
(Bos
taurus) 		4 / 6 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.01A 3ag1N-2b39A:
3.1
3ag1W-2b39A:
undetectable		 3ag1N-2b39A:
14.95
3ag1W-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG2_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.19A 3ag2J-2b39A:
undetectable		 3ag2J-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AG4_J_CHDJ60_0
(CYTOCHROME C OXIDASE
POLYPEPTIDE 7A1)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.18A 3ag4J-2b39A:
undetectable		 3ag4J-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AX9_A_SALA1341_1
(XANTHINE
DEHYDROGENASE/OXIDAS
E)		 2b39 C3
(Bos
taurus) 		4 / 8 LEU A 850
PHE A 828
VAL A 911
ALA A 914
 None
 0.96A 3ax9A-2b39A:
undetectable		 3ax9A-2b39A:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AX9_A_SALA1341_1
(XANTHINE
DEHYDROGENASE/OXIDAS
E)		 2b39 C3
(Bos
taurus) 		4 / 8 LEU A1045
SER A1044
THR A1020
ALA A1088
 None
 0.97A 3ax9A-2b39A:
undetectable		 3ax9A-2b39A:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3M_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 3b3mA-2b39A:
undetectable
3b3mB-2b39A:
undetectable		 3b3mA-2b39A:
13.58
3b3mB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3M_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3b3mA-2b39A:
undetectable
3b3mB-2b39A:
undetectable		 3b3mA-2b39A:
13.58
3b3mB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3N_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 3b3nA-2b39A:
undetectable
3b3nB-2b39A:
undetectable		 3b3nA-2b39A:
13.58
3b3nB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3N_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 3b3nA-2b39A:
undetectable
3b3nB-2b39A:
undetectable		 3b3nA-2b39A:
13.58
3b3nB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3O_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 3b3oA-2b39A:
undetectable
3b3oB-2b39A:
undetectable		 3b3oA-2b39A:
13.58
3b3oB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3O_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3b3oA-2b39A:
undetectable
3b3oB-2b39A:
undetectable		 3b3oA-2b39A:
13.58
3b3oB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 3b3pA-2b39A:
undetectable
3b3pB-2b39A:
2.3		 3b3pA-2b39A:
13.58
3b3pB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3b3pA-2b39A:
undetectable
3b3pB-2b39A:
2.3		 3b3pA-2b39A:
13.58
3b3pB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_C_SVRC505_2
(PHOSPHOLIPASE A2)		 2b39 C3
(Bos
taurus) 		4 / 5 VAL A 107
VAL A  59
GLN A  67
PHE A 104
 None
 1.34A 3bjwH-2b39A:
undetectable		 3bjwH-2b39A:
5.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_G_SVRG506_2
(PHOSPHOLIPASE A2)		 2b39 C3
(Bos
taurus) 		4 / 5 VAL A 107
VAL A  59
GLN A  67
PHE A 104
 None
 1.37A 3bjwB-2b39A:
undetectable		 3bjwB-2b39A:
5.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWY_A_SAMA301_1
(COMT PROTEIN)		 2b39 C3
(Bos
taurus) 		3 / 3 SER A 797
GLU A 767
ASP A 597
 None
 0.84A 3bwyA-2b39A:
undetectable		 3bwyA-2b39A:
8.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CCF_B_BEZB261_0
(CYCLOPROPANE-FATTY-A
CYL-PHOSPHOLIPID
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 8 HIS A1125
ILE A1190
PHE A1145
TYR A1234
 None
 1.31A 3ccfB-2b39A:
undetectable		 3ccfB-2b39A:
10.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3dqrA-2b39A:
undetectable
3dqrB-2b39A:
undetectable		 3dqrA-2b39A:
13.74
3dqrB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3dqrA-2b39A:
undetectable
3dqrB-2b39A:
undetectable		 3dqrA-2b39A:
13.74
3dqrB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DTU_C_DXCC576_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 2)		 2b39 C3
(Bos
taurus) 		4 / 8 ALA A1194
ALA A1196
ILE A1148
HIS A1125
 None
 0.69A 3dtuC-2b39A:
undetectable
3dtuD-2b39A:
undetectable		 3dtuC-2b39A:
15.81
3dtuD-2b39A:
9.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FC5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 3fc5A-2b39A:
undetectable
3fc5B-2b39A:
2.3		 3fc5A-2b39A:
13.58
3fc5B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FC5_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3fc5A-2b39A:
undetectable
3fc5B-2b39A:
2.3		 3fc5A-2b39A:
13.58
3fc5B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FXR_A_ASCA3001_0
(LYSR TYPE REGULATOR
OF TSAMBCD)		 2b39 C3
(Bos
taurus) 		4 / 8 ASN A 451
ARG A 476
PRO A 365
PRO A 443
 None
 0.95A 3fxrA-2b39A:
undetectable		 3fxrA-2b39A:
11.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HKU_A_TORA300_2
(CARBONIC ANHYDRASE 2)		 2b39 C3
(Bos
taurus) 		3 / 3 GLU A  45
HIS A  47
THR A 489
 None
 0.87A 3hkuA-2b39A:
undetectable		 3hkuA-2b39A:
9.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3hsnA-2b39A:
undetectable
3hsnB-2b39A:
undetectable		 3hsnA-2b39A:
13.58
3hsnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSN_B_H4BB1760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3hsnA-2b39A:
undetectable
3hsnB-2b39A:
undetectable		 3hsnA-2b39A:
13.58
3hsnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3hsoA-2b39A:
undetectable
3hsoB-2b39A:
undetectable		 3hsoA-2b39A:
13.58
3hsoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSO_B_H4BB1760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 0.98A 3hsoA-2b39A:
undetectable
3hsoB-2b39A:
undetectable		 3hsoA-2b39A:
13.58
3hsoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 3hspA-2b39A:
undetectable
3hspB-2b39A:
undetectable		 3hspA-2b39A:
13.58
3hspB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSP_B_H4BB1760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.01A 3hspA-2b39A:
undetectable
3hspB-2b39A:
undetectable		 3hspA-2b39A:
13.58
3hspB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3J7Z_A_ERYA9000_0
(23S RRNA
50S RIBOSOMAL
PROTEIN L22
ERMCL NASCENT CHAIN)		 2b39 C3
(Bos
taurus) 		3 / 3 LYS A1502
ILE A1583
PHE A1582
 None
 0.89A 3j7zS-2b39A:
undetectable
3j7za-2b39A:
undetectable		 3j7zS-2b39A:
5.03
3j7za-2b39A:
1.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jt3A-2b39A:
undetectable
3jt3B-2b39A:
undetectable		 3jt3A-2b39A:
13.58
3jt3B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3jt3A-2b39A:
undetectable
3jt3B-2b39A:
undetectable		 3jt3A-2b39A:
13.58
3jt3B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3jt4A-2b39A:
undetectable
3jt4B-2b39A:
undetectable		 3jt4A-2b39A:
13.58
3jt4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3jt4A-2b39A:
undetectable
3jt4B-2b39A:
undetectable		 3jt4A-2b39A:
13.58
3jt4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3jt5A-2b39A:
undetectable
3jt5B-2b39A:
undetectable		 3jt5A-2b39A:
13.58
3jt5B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3jt5A-2b39A:
undetectable
3jt5B-2b39A:
undetectable		 3jt5A-2b39A:
13.58
3jt5B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3jt6A-2b39A:
undetectable
3jt6B-2b39A:
undetectable		 3jt6A-2b39A:
13.58
3jt6B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3jt6A-2b39A:
undetectable
3jt6B-2b39A:
undetectable		 3jt6A-2b39A:
13.58
3jt6B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT7_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3jt7A-2b39A:
undetectable
3jt7B-2b39A:
undetectable		 3jt7A-2b39A:
13.58
3jt7B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT7_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3jt7A-2b39A:
undetectable
3jt7B-2b39A:
undetectable		 3jt7A-2b39A:
13.58
3jt7B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT8_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3jt8A-2b39A:
undetectable
3jt8B-2b39A:
undetectable		 3jt8A-2b39A:
13.58
3jt8B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT8_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3jt8A-2b39A:
undetectable
3jt8B-2b39A:
undetectable		 3jt8A-2b39A:
13.58
3jt8B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT9_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3jt9A-2b39A:
undetectable
3jt9B-2b39A:
undetectable		 3jt9A-2b39A:
13.58
3jt9B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT9_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 3jt9A-2b39A:
undetectable
3jt9B-2b39A:
undetectable		 3jt9A-2b39A:
13.58
3jt9B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JTA_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 3jtaA-2b39A:
undetectable
3jtaB-2b39A:
undetectable		 3jtaA-2b39A:
13.58
3jtaB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JTA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3jtaA-2b39A:
undetectable
3jtaB-2b39A:
undetectable		 3jtaA-2b39A:
13.58
3jtaB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jwsA-2b39A:
undetectable
3jwsB-2b39A:
undetectable		 3jwsA-2b39A:
13.58
3jwsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWS_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 3jwsA-2b39A:
undetectable
3jwsB-2b39A:
undetectable		 3jwsA-2b39A:
13.58
3jwsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3jwtA-2b39A:
undetectable
3jwtB-2b39A:
undetectable		 3jwtA-2b39A:
13.58
3jwtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 3jwtA-2b39A:
undetectable
3jwtB-2b39A:
undetectable		 3jwtA-2b39A:
13.58
3jwtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3jwuA-2b39A:
undetectable
3jwuB-2b39A:
undetectable		 3jwuA-2b39A:
13.58
3jwuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 3jwuA-2b39A:
undetectable
3jwuB-2b39A:
undetectable		 3jwuA-2b39A:
13.58
3jwuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3jwvA-2b39A:
undetectable
3jwvB-2b39A:
undetectable		 3jwvA-2b39A:
13.58
3jwvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 3jwvA-2b39A:
undetectable
3jwvB-2b39A:
undetectable		 3jwvA-2b39A:
13.58
3jwvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jx0A-2b39A:
undetectable
3jx0B-2b39A:
undetectable		 3jx0A-2b39A:
13.64
3jx0B-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3jx0A-2b39A:
undetectable
3jx0B-2b39A:
undetectable		 3jx0A-2b39A:
13.64
3jx0B-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX1_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jx1A-2b39A:
undetectable
3jx1B-2b39A:
undetectable		 3jx1A-2b39A:
13.64
3jx1B-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX1_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3jx1A-2b39A:
undetectable
3jx1B-2b39A:
undetectable		 3jx1A-2b39A:
13.64
3jx1B-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jx2A-2b39A:
undetectable
3jx2B-2b39A:
undetectable		 3jx2A-2b39A:
13.74
3jx2B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3jx2A-2b39A:
undetectable
3jx2B-2b39A:
undetectable		 3jx2A-2b39A:
13.74
3jx2B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jx3A-2b39A:
undetectable
3jx3B-2b39A:
undetectable		 3jx3A-2b39A:
13.74
3jx3B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3jx3A-2b39A:
undetectable
3jx3B-2b39A:
undetectable		 3jx3A-2b39A:
13.74
3jx3B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3jx4A-2b39A:
undetectable
3jx4B-2b39A:
undetectable		 3jx4A-2b39A:
13.74
3jx4B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3jx5A-2b39A:
undetectable
3jx5B-2b39A:
undetectable		 3jx5A-2b39A:
13.74
3jx5B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3jx5A-2b39A:
undetectable
3jx5B-2b39A:
undetectable		 3jx5A-2b39A:
13.74
3jx5B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.13A 3jx6A-2b39A:
undetectable
3jx6B-2b39A:
undetectable		 3jx6A-2b39A:
13.74
3jx6B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3jx6A-2b39A:
undetectable
3jx6B-2b39A:
undetectable		 3jx6A-2b39A:
13.74
3jx6B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N2R_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3n2rA-2b39A:
undetectable
3n2rB-2b39A:
undetectable		 3n2rA-2b39A:
13.58
3n2rB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N2R_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3n2rA-2b39A:
undetectable
3n2rB-2b39A:
undetectable		 3n2rA-2b39A:
13.58
3n2rB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5V_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.13A 3n5vA-2b39A:
undetectable
3n5vB-2b39A:
undetectable		 3n5vA-2b39A:
13.58
3n5vB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Y_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.15A 3n5yA-2b39A:
undetectable
3n5yB-2b39A:
undetectable		 3n5yA-2b39A:
13.58
3n5yB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Y_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 3n5yA-2b39A:
undetectable
3n5yB-2b39A:
undetectable		 3n5yA-2b39A:
13.58
3n5yB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Z_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.16A 3n5zA-2b39A:
undetectable
3n5zB-2b39A:
undetectable		 3n5zA-2b39A:
13.58
3n5zB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Z_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.11A 3n5zA-2b39A:
undetectable
3n5zB-2b39A:
undetectable		 3n5zA-2b39A:
13.58
3n5zB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3nljA-2b39A:
undetectable
3nljB-2b39A:
undetectable		 3nljA-2b39A:
13.74
3nljB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3nljA-2b39A:
undetectable
3nljB-2b39A:
undetectable		 3nljA-2b39A:
13.74
3nljB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLK_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nlkA-2b39A:
undetectable
3nlkB-2b39A:
undetectable		 3nlkA-2b39A:
13.58
3nlkB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 3nlkA-2b39A:
undetectable
3nlkB-2b39A:
undetectable		 3nlkA-2b39A:
13.58
3nlkB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3nlmA-2b39A:
undetectable
3nlmB-2b39A:
undetectable		 3nlmA-2b39A:
13.58
3nlmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3nlmA-2b39A:
undetectable
3nlmB-2b39A:
undetectable		 3nlmA-2b39A:
13.58
3nlmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nlnA-2b39A:
undetectable
3nlnB-2b39A:
undetectable		 3nlnA-2b39A:
13.58
3nlnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 3nlnA-2b39A:
undetectable
3nlnB-2b39A:
undetectable		 3nlnA-2b39A:
13.58
3nlnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.04A 3nloA-2b39A:
undetectable
3nloB-2b39A:
undetectable		 3nloA-2b39A:
13.58
3nloB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3nloA-2b39A:
undetectable
3nloB-2b39A:
undetectable		 3nloA-2b39A:
13.58
3nloB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nlpA-2b39A:
undetectable
3nlpB-2b39A:
undetectable		 3nlpA-2b39A:
13.74
3nlpB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3nlpA-2b39A:
undetectable
3nlpB-2b39A:
undetectable		 3nlpA-2b39A:
13.74
3nlpB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nlqA-2b39A:
undetectable
3nlqB-2b39A:
undetectable		 3nlqA-2b39A:
13.74
3nlqB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3nlqA-2b39A:
undetectable
3nlqB-2b39A:
undetectable		 3nlqA-2b39A:
13.74
3nlqB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nlrA-2b39A:
undetectable
3nlrB-2b39A:
undetectable		 3nlrA-2b39A:
13.74
3nlrB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3nlrA-2b39A:
undetectable
3nlrB-2b39A:
undetectable		 3nlrA-2b39A:
13.74
3nlrB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3nlvA-2b39A:
undetectable
3nlvB-2b39A:
undetectable		 3nlvA-2b39A:
13.58
3nlvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3nlvA-2b39A:
undetectable
3nlvB-2b39A:
undetectable		 3nlvA-2b39A:
13.58
3nlvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3nlwA-2b39A:
undetectable
3nlwB-2b39A:
undetectable		 3nlwA-2b39A:
13.58
3nlwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3nlwA-2b39A:
undetectable
3nlwB-2b39A:
undetectable		 3nlwA-2b39A:
13.58
3nlwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLX_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3nlxA-2b39A:
undetectable
3nlxB-2b39A:
undetectable		 3nlxA-2b39A:
13.58
3nlxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLX_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3nlxA-2b39A:
undetectable
3nlxB-2b39A:
undetectable		 3nlxA-2b39A:
13.58
3nlxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLY_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.14A 3nlyA-2b39A:
undetectable
3nlyB-2b39A:
undetectable		 3nlyA-2b39A:
13.58
3nlyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLY_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3nlyA-2b39A:
undetectable
3nlyB-2b39A:
undetectable		 3nlyA-2b39A:
13.58
3nlyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLZ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nlzA-2b39A:
undetectable
3nlzB-2b39A:
undetectable		 3nlzA-2b39A:
13.58
3nlzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLZ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3nlzA-2b39A:
undetectable
3nlzB-2b39A:
undetectable		 3nlzA-2b39A:
13.58
3nlzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NM0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3nm0A-2b39A:
2.5
3nm0B-2b39A:
undetectable		 3nm0A-2b39A:
13.58
3nm0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NM0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 3nm0A-2b39A:
2.5
3nm0B-2b39A:
undetectable		 3nm0A-2b39A:
13.58
3nm0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNY_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3nnyA-2b39A:
undetectable
3nnyB-2b39A:
undetectable		 3nnyA-2b39A:
13.58
3nnyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNY_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3nnyA-2b39A:
undetectable
3nnyB-2b39A:
undetectable		 3nnyA-2b39A:
13.58
3nnyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNZ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 3nnzA-2b39A:
undetectable
3nnzB-2b39A:
undetectable		 3nnzA-2b39A:
13.58
3nnzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNZ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3nnzA-2b39A:
undetectable
3nnzB-2b39A:
undetectable		 3nnzA-2b39A:
13.58
3nnzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNE_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 3pneA-2b39A:
2.5
3pneB-2b39A:
undetectable		 3pneA-2b39A:
13.58
3pneB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNE_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3pneA-2b39A:
2.5
3pneB-2b39A:
undetectable		 3pneA-2b39A:
13.58
3pneB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNF_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3pnfA-2b39A:
undetectable
3pnfB-2b39A:
undetectable		 3pnfA-2b39A:
13.58
3pnfB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNF_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3pnfA-2b39A:
undetectable
3pnfB-2b39A:
undetectable		 3pnfA-2b39A:
13.58
3pnfB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNG_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3pngA-2b39A:
undetectable
3pngB-2b39A:
undetectable		 3pngA-2b39A:
13.58
3pngB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNG_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 3pngA-2b39A:
undetectable
3pngB-2b39A:
undetectable		 3pngA-2b39A:
13.58
3pngB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3POC_B_ACRB665_1
(ALPHA-GLUCOSIDASE)		 2b39 C3
(Bos
taurus) 		4 / 6 LYS A1243
ASP A1244
TYR A1245
ASP A1246
 None
 0.88A 3pocB-2b39A:
undetectable		 3pocB-2b39A:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PRS_A_RITA1001_1
(ENDOTHIAPEPSIN)		 2b39 C3
(Bos
taurus) 		5 / 10 ILE A1156
ALA A1153
TYR A1080
THR A1268
ILE A1190
 None
 1.24A 3prsA-2b39A:
undetectable		 3prsA-2b39A:
11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q99_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.13A 3q99A-2b39A:
undetectable
3q99B-2b39A:
undetectable		 3q99A-2b39A:
13.58
3q99B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q99_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 3q99A-2b39A:
undetectable
3q99B-2b39A:
undetectable		 3q99A-2b39A:
13.58
3q99B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q9A_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3q9aA-2b39A:
undetectable
3q9aB-2b39A:
undetectable		 3q9aA-2b39A:
13.58
3q9aB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q9A_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3q9aA-2b39A:
undetectable
3q9aB-2b39A:
undetectable		 3q9aA-2b39A:
13.58
3q9aB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3REQ_A_ADNA801_1
(METHYLMALONYL-COA
MUTASE)		 2b39 C3
(Bos
taurus) 		4 / 4 TYR A1480
TYR A1445
GLU A1432
GLY A1008
 None
 1.37A 3reqA-2b39A:
0.4		 3reqA-2b39A:
18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQJ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3rqjA-2b39A:
undetectable
3rqjB-2b39A:
undetectable		 3rqjA-2b39A:
13.58
3rqjB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQJ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3rqjA-2b39A:
undetectable
3rqjB-2b39A:
undetectable		 3rqjA-2b39A:
13.58
3rqjB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQK_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3rqkA-2b39A:
0.0
3rqkB-2b39A:
0.0		 3rqkA-2b39A:
13.58
3rqkB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3rqkA-2b39A:
undetectable
3rqkB-2b39A:
undetectable		 3rqkA-2b39A:
13.58
3rqkB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3rqlA-2b39A:
2.5
3rqlB-2b39A:
undetectable		 3rqlA-2b39A:
13.58
3rqlB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQL_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3rqlA-2b39A:
2.5
3rqlB-2b39A:
undetectable		 3rqlA-2b39A:
13.58
3rqlB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3rqmA-2b39A:
undetectable
3rqmB-2b39A:
undetectable		 3rqmA-2b39A:
13.58
3rqmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3rqmA-2b39A:
undetectable
3rqmB-2b39A:
undetectable		 3rqmA-2b39A:
13.58
3rqmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3rqnA-2b39A:
2.5
3rqnB-2b39A:
undetectable		 3rqnA-2b39A:
13.58
3rqnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3rqnA-2b39A:
2.5
3rqnB-2b39A:
undetectable		 3rqnA-2b39A:
13.58
3rqnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SVP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3svpA-2b39A:
undetectable
3svpB-2b39A:
undetectable		 3svpA-2b39A:
13.58
3svpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SVP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 3svpA-2b39A:
0.0
3svpB-2b39A:
0.0		 3svpA-2b39A:
13.58
3svpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SVQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3svqA-2b39A:
undetectable
3svqB-2b39A:
undetectable		 3svqA-2b39A:
13.58
3svqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SVQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3svqA-2b39A:
undetectable
3svqB-2b39A:
undetectable		 3svqA-2b39A:
13.58
3svqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYE_B_YTZB902_1
(DIHYDROPTEROATE
SYNTHASE)		 2b39 C3
(Bos
taurus) 		3 / 3 PHE A1058
LYS A1430
SER A1429
 None
 0.90A 3tyeB-2b39A:
undetectable		 3tyeB-2b39A:
10.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 3tylA-2b39A:
undetectable
3tylB-2b39A:
undetectable		 3tylA-2b39A:
13.58
3tylB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYL_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 3tylA-2b39A:
undetectable
3tylB-2b39A:
undetectable		 3tylA-2b39A:
13.58
3tylB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3tymA-2b39A:
undetectable
3tymB-2b39A:
undetectable		 3tymA-2b39A:
13.58
3tymB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 3tymA-2b39A:
undetectable
3tymB-2b39A:
undetectable		 3tymA-2b39A:
13.58
3tymB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3tynA-2b39A:
undetectable
3tynB-2b39A:
undetectable		 3tynA-2b39A:
13.58
3tynB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3tynA-2b39A:
undetectable
3tynB-2b39A:
undetectable		 3tynA-2b39A:
13.58
3tynB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 3tyoA-2b39A:
undetectable
3tyoB-2b39A:
undetectable		 3tyoA-2b39A:
13.58
3tyoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3tyoA-2b39A:
undetectable
3tyoB-2b39A:
undetectable		 3tyoA-2b39A:
13.58
3tyoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3ufoA-2b39A:
undetectable
3ufoB-2b39A:
undetectable		 3ufoA-2b39A:
13.58
3ufoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3ufoA-2b39A:
undetectable
3ufoB-2b39A:
undetectable		 3ufoA-2b39A:
13.58
3ufoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 3ufpA-2b39A:
undetectable
3ufpB-2b39A:
2.3		 3ufpA-2b39A:
13.58
3ufpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 3ufpA-2b39A:
undetectable
3ufpB-2b39A:
2.3		 3ufpA-2b39A:
13.58
3ufpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 3ufqA-2b39A:
undetectable
3ufqB-2b39A:
undetectable		 3ufqA-2b39A:
13.58
3ufqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3ufqA-2b39A:
undetectable
3ufqB-2b39A:
undetectable		 3ufqA-2b39A:
13.58
3ufqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.16A 3ufrA-2b39A:
undetectable
3ufrB-2b39A:
undetectable		 3ufrA-2b39A:
13.58
3ufrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3ufrA-2b39A:
undetectable
3ufrB-2b39A:
undetectable		 3ufrA-2b39A:
13.58
3ufrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3ufsA-2b39A:
undetectable
3ufsB-2b39A:
undetectable		 3ufsA-2b39A:
13.58
3ufsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFS_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3ufsA-2b39A:
undetectable
3ufsB-2b39A:
undetectable		 3ufsA-2b39A:
13.58
3ufsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 3uftA-2b39A:
undetectable
3uftB-2b39A:
undetectable		 3uftA-2b39A:
13.58
3uftB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 3uftA-2b39A:
undetectable
3uftB-2b39A:
undetectable		 3uftA-2b39A:
13.58
3uftB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 3ufuA-2b39A:
undetectable
3ufuB-2b39A:
undetectable		 3ufuA-2b39A:
13.58
3ufuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 3ufuA-2b39A:
undetectable
3ufuB-2b39A:
undetectable		 3ufuA-2b39A:
13.58
3ufuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.12A 3ufvA-2b39A:
undetectable
3ufvB-2b39A:
undetectable		 3ufvA-2b39A:
13.58
3ufvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 3ufvA-2b39A:
undetectable
3ufvB-2b39A:
undetectable		 3ufvA-2b39A:
13.58
3ufvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 3ufwA-2b39A:
undetectable
3ufwB-2b39A:
undetectable		 3ufwA-2b39A:
13.58
3ufwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 3ufwA-2b39A:
undetectable
3ufwB-2b39A:
undetectable		 3ufwA-2b39A:
13.58
3ufwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_E_ACTE502_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 2b39 C3
(Bos
taurus) 		3 / 3 LYS A1035
ARG A 998
LEU A1318
 None
 1.32A 3v4tE-2b39A:
undetectable		 3v4tE-2b39A:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WXO_A_NIZA804_1
(CATALASE-PEROXIDASE)		 2b39 C3
(Bos
taurus) 		3 / 3 ASN A1466
GLU A 845
ARG A 847
 None
 1.10A 3wxoA-2b39A:
1.5		 3wxoA-2b39A:
17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A81_A_DXCA1161_0
(MAJOR POLLEN
ALLERGEN BET V 1-A)		 2b39 C3
(Bos
taurus) 		5 / 12 ILE A1401
ILE A1387
VAL A1364
MET A1406
LEU A1442
 None
 1.19A 4a81A-2b39A:
undetectable		 4a81A-2b39A:
6.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4c39A-2b39A:
undetectable
4c39B-2b39A:
undetectable		 4c39A-2b39A:
13.58
4c39B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4c39A-2b39A:
undetectable
4c39B-2b39A:
undetectable		 4c39A-2b39A:
13.58
4c39B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4camA-2b39A:
undetectable
4camB-2b39A:
undetectable		 4camA-2b39A:
13.58
4camB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4camA-2b39A:
undetectable
4camB-2b39A:
undetectable		 4camA-2b39A:
13.58
4camB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4canA-2b39A:
undetectable
4canB-2b39A:
undetectable		 4canA-2b39A:
13.58
4canB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4canA-2b39A:
undetectable
4canB-2b39A:
undetectable		 4canA-2b39A:
13.58
4canB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.04A 4caoA-2b39A:
undetectable
4caoB-2b39A:
undetectable		 4caoA-2b39A:
13.58
4caoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4caoA-2b39A:
undetectable
4caoB-2b39A:
undetectable		 4caoA-2b39A:
13.58
4caoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4capA-2b39A:
undetectable
4capB-2b39A:
undetectable		 4capA-2b39A:
13.58
4capB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4capA-2b39A:
undetectable
4capB-2b39A:
undetectable		 4capA-2b39A:
13.58
4capB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4caqA-2b39A:
undetectable
4caqB-2b39A:
undetectable		 4caqA-2b39A:
13.58
4caqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4caqA-2b39A:
undetectable
4caqB-2b39A:
undetectable		 4caqA-2b39A:
13.58
4caqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CDT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4cdtA-2b39A:
undetectable
4cdtB-2b39A:
undetectable		 4cdtA-2b39A:
13.58
4cdtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CDT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4cdtA-2b39A:
undetectable
4cdtB-2b39A:
undetectable		 4cdtA-2b39A:
13.58
4cdtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4ctpA-2b39A:
undetectable
4ctpB-2b39A:
undetectable		 4ctpA-2b39A:
13.58
4ctpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4ctpA-2b39A:
undetectable
4ctpB-2b39A:
undetectable		 4ctpA-2b39A:
13.58
4ctpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4ctqA-2b39A:
undetectable
4ctqB-2b39A:
undetectable		 4ctqA-2b39A:
13.58
4ctqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4ctqA-2b39A:
undetectable
4ctqB-2b39A:
undetectable		 4ctqA-2b39A:
13.58
4ctqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4ctrA-2b39A:
undetectable
4ctrB-2b39A:
undetectable		 4ctrA-2b39A:
13.58
4ctrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4ctrA-2b39A:
undetectable
4ctrB-2b39A:
undetectable		 4ctrA-2b39A:
13.58
4ctrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4cttA-2b39A:
undetectable
4cttB-2b39A:
undetectable		 4cttA-2b39A:
13.58
4cttB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 4cttA-2b39A:
undetectable
4cttB-2b39A:
undetectable		 4cttA-2b39A:
13.58
4cttB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4ctuA-2b39A:
undetectable
4ctuB-2b39A:
undetectable		 4ctuA-2b39A:
13.58
4ctuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4ctuA-2b39A:
undetectable
4ctuB-2b39A:
undetectable		 4ctuA-2b39A:
13.58
4ctuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTV_A_H4BA1718_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4ctvA-2b39A:
undetectable
4ctvB-2b39A:
undetectable		 4ctvA-2b39A:
13.58
4ctvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTV_B_H4BB1720_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 4ctvA-2b39A:
undetectable
4ctvB-2b39A:
undetectable		 4ctvA-2b39A:
13.58
4ctvB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTW_A_H4BA1718_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4ctwA-2b39A:
undetectable
4ctwB-2b39A:
undetectable		 4ctwA-2b39A:
13.58
4ctwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTW_B_H4BB1720_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4ctwA-2b39A:
undetectable
4ctwB-2b39A:
undetectable		 4ctwA-2b39A:
13.58
4ctwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTX_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4ctxA-2b39A:
undetectable
4ctxB-2b39A:
undetectable		 4ctxA-2b39A:
13.58
4ctxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTX_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4ctxA-2b39A:
undetectable
4ctxB-2b39A:
undetectable		 4ctxA-2b39A:
13.58
4ctxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4cx3A-2b39A:
undetectable
4cx3B-2b39A:
undetectable		 4cx3A-2b39A:
13.74
4cx3B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4cx3A-2b39A:
undetectable
4cx3B-2b39A:
undetectable		 4cx3A-2b39A:
13.74
4cx3B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4cx4A-2b39A:
undetectable
4cx4B-2b39A:
undetectable		 4cx4A-2b39A:
13.74
4cx4B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4cx4A-2b39A:
undetectable
4cx4B-2b39A:
undetectable		 4cx4A-2b39A:
13.74
4cx4B-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4cx5A-2b39A:
undetectable
4cx5B-2b39A:
undetectable		 4cx5A-2b39A:
13.69
4cx5B-2b39A:
13.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 4cx5A-2b39A:
undetectable
4cx5B-2b39A:
undetectable		 4cx5A-2b39A:
13.69
4cx5B-2b39A:
13.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4cx6A-2b39A:
undetectable
4cx6B-2b39A:
undetectable		 4cx6A-2b39A:
13.69
4cx6B-2b39A:
13.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4cx6A-2b39A:
undetectable
4cx6B-2b39A:
undetectable		 4cx6A-2b39A:
13.69
4cx6B-2b39A:
13.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4d1nA-2b39A:
undetectable
4d1nB-2b39A:
undetectable		 4d1nA-2b39A:
13.25
4d1nB-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 4d1nA-2b39A:
undetectable
4d1nB-2b39A:
undetectable		 4d1nA-2b39A:
13.25
4d1nB-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_C_H4BC760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.04A 4d1nC-2b39A:
undetectable
4d1nD-2b39A:
undetectable		 4d1nC-2b39A:
13.25
4d1nD-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_D_H4BD760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4d1nC-2b39A:
undetectable
4d1nD-2b39A:
undetectable		 4d1nC-2b39A:
13.25
4d1nD-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Y_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4d2yA-2b39A:
undetectable
4d2yB-2b39A:
undetectable		 4d2yA-2b39A:
13.58
4d2yB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Y_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4d2yA-2b39A:
undetectable
4d2yB-2b39A:
undetectable		 4d2yA-2b39A:
13.58
4d2yB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Z_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4d2zA-2b39A:
undetectable
4d2zB-2b39A:
undetectable		 4d2zA-2b39A:
13.58
4d2zB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Z_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4d2zA-2b39A:
undetectable
4d2zB-2b39A:
undetectable		 4d2zA-2b39A:
13.58
4d2zB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D30_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.04A 4d30A-2b39A:
undetectable
4d30B-2b39A:
undetectable		 4d30A-2b39A:
13.58
4d30B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D30_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 4d30A-2b39A:
undetectable
4d30B-2b39A:
undetectable		 4d30A-2b39A:
13.58
4d30B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D31_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4d31A-2b39A:
undetectable
4d31B-2b39A:
undetectable		 4d31A-2b39A:
13.58
4d31B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D31_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4d31A-2b39A:
undetectable
4d31B-2b39A:
undetectable		 4d31A-2b39A:
13.58
4d31B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D32_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4d32A-2b39A:
undetectable
4d32B-2b39A:
undetectable		 4d32A-2b39A:
13.58
4d32B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D32_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 4d32A-2b39A:
undetectable
4d32B-2b39A:
undetectable		 4d32A-2b39A:
13.58
4d32B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D3B_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4d3bA-2b39A:
2.4
4d3bB-2b39A:
undetectable		 4d3bA-2b39A:
13.58
4d3bB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D3B_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4d3bA-2b39A:
2.4
4d3bB-2b39A:
undetectable		 4d3bA-2b39A:
13.58
4d3bB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D7O_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4d7oA-2b39A:
undetectable
4d7oB-2b39A:
2.4		 4d7oA-2b39A:
13.58
4d7oB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D7O_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4d7oA-2b39A:
undetectable
4d7oB-2b39A:
2.4		 4d7oA-2b39A:
13.58
4d7oB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4euxA-2b39A:
undetectable
4euxB-2b39A:
2.3		 4euxA-2b39A:
13.58
4euxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4euxA-2b39A:
undetectable
4euxB-2b39A:
2.3		 4euxA-2b39A:
13.58
4euxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FFW_B_715B801_1
(DIPEPTIDYL PEPTIDASE
4)		 2b39 C3
(Bos
taurus) 		5 / 12 GLU A1127
GLY A1130
TYR A1391
SER A1479
TYR A1227
 None
 1.42A 4ffwB-2b39A:
undetectable		 4ffwB-2b39A:
18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4fvwA-2b39A:
undetectable
4fvwB-2b39A:
undetectable		 4fvwA-2b39A:
13.58
4fvwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4fvwA-2b39A:
undetectable
4fvwB-2b39A:
undetectable		 4fvwA-2b39A:
13.58
4fvwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4fvxA-2b39A:
undetectable
4fvxB-2b39A:
undetectable		 4fvxA-2b39A:
13.58
4fvxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4fvxA-2b39A:
undetectable
4fvxB-2b39A:
undetectable		 4fvxA-2b39A:
13.58
4fvxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4fvyA-2b39A:
undetectable
4fvyB-2b39A:
undetectable		 4fvyA-2b39A:
13.58
4fvyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4fvyA-2b39A:
undetectable
4fvyB-2b39A:
undetectable		 4fvyA-2b39A:
13.58
4fvyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4fvzA-2b39A:
undetectable
4fvzB-2b39A:
undetectable		 4fvzA-2b39A:
13.58
4fvzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 4fvzA-2b39A:
undetectable
4fvzB-2b39A:
undetectable		 4fvzA-2b39A:
13.58
4fvzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FW0_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4fw0A-2b39A:
undetectable
4fw0B-2b39A:
undetectable		 4fw0A-2b39A:
13.58
4fw0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FW0_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4fw0A-2b39A:
undetectable
4fw0B-2b39A:
undetectable		 4fw0A-2b39A:
13.58
4fw0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GQE_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4gqeA-2b39A:
undetectable
4gqeB-2b39A:
undetectable		 4gqeA-2b39A:
13.58
4gqeB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GQE_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4gqeA-2b39A:
undetectable
4gqeB-2b39A:
undetectable		 4gqeA-2b39A:
13.58
4gqeB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I41_A_MIXA501_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 2b39 C3
(Bos
taurus) 		5 / 12 ILE A 330
THR A1419
ASP A 752
ILE A 754
GLU A 757
 None
 1.27A 4i41A-2b39A:
undetectable		 4i41A-2b39A:
10.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IMT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4imtA-2b39A:
undetectable
4imtB-2b39A:
undetectable		 4imtA-2b39A:
13.58
4imtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IMT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 4imtA-2b39A:
undetectable
4imtB-2b39A:
undetectable		 4imtA-2b39A:
13.58
4imtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IMW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.12A 4imwA-2b39A:
undetectable
4imwB-2b39A:
2.3		 4imwA-2b39A:
13.58
4imwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IMW_A_H4BA805_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4imwA-2b39A:
undetectable
4imwB-2b39A:
2.3		 4imwA-2b39A:
13.58
4imwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSF_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.13A 4jsfA-2b39A:
undetectable
4jsfB-2b39A:
undetectable		 4jsfA-2b39A:
13.58
4jsfB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSF_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 4jsfA-2b39A:
undetectable
4jsfB-2b39A:
undetectable		 4jsfA-2b39A:
13.58
4jsfB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSG_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4jsgA-2b39A:
undetectable
4jsgB-2b39A:
undetectable		 4jsgA-2b39A:
13.58
4jsgB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSG_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 4jsgA-2b39A:
undetectable
4jsgB-2b39A:
undetectable		 4jsgA-2b39A:
13.58
4jsgB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSH_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4jshA-2b39A:
undetectable
4jshB-2b39A:
undetectable		 4jshA-2b39A:
13.58
4jshB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSH_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4jshA-2b39A:
0.0
4jshB-2b39A:
0.0		 4jshA-2b39A:
13.58
4jshB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4jsiA-2b39A:
undetectable
4jsiB-2b39A:
undetectable		 4jsiA-2b39A:
13.58
4jsiB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4jsiA-2b39A:
undetectable
4jsiB-2b39A:
undetectable		 4jsiA-2b39A:
13.58
4jsiB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSJ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4jsjA-2b39A:
undetectable
4jsjB-2b39A:
undetectable		 4jsjA-2b39A:
13.58
4jsjB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSJ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4jsjA-2b39A:
undetectable
4jsjB-2b39A:
undetectable		 4jsjA-2b39A:
13.58
4jsjB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5D_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4k5dA-2b39A:
undetectable
4k5dB-2b39A:
undetectable		 4k5dA-2b39A:
13.58
4k5dB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5D_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4k5dA-2b39A:
undetectable
4k5dB-2b39A:
undetectable		 4k5dA-2b39A:
13.58
4k5dB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5E_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4k5eA-2b39A:
undetectable
4k5eB-2b39A:
undetectable		 4k5eA-2b39A:
13.58
4k5eB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5E_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4k5eA-2b39A:
undetectable
4k5eB-2b39A:
undetectable		 4k5eA-2b39A:
13.58
4k5eB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5F_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4k5fA-2b39A:
undetectable
4k5fB-2b39A:
undetectable		 4k5fA-2b39A:
13.58
4k5fB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5F_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4k5fA-2b39A:
undetectable
4k5fB-2b39A:
undetectable		 4k5fA-2b39A:
13.58
4k5fB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5G_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4k5gA-2b39A:
undetectable
4k5gB-2b39A:
undetectable		 4k5gA-2b39A:
13.58
4k5gB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5G_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4k5gA-2b39A:
undetectable
4k5gB-2b39A:
undetectable		 4k5gA-2b39A:
13.58
4k5gB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCH_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4kchA-2b39A:
undetectable
4kchB-2b39A:
undetectable		 4kchA-2b39A:
13.58
4kchB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCH_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4kchA-2b39A:
undetectable
4kchB-2b39A:
undetectable		 4kchA-2b39A:
13.58
4kchB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4kciA-2b39A:
undetectable
4kciB-2b39A:
undetectable		 4kciA-2b39A:
13.58
4kciB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4kciA-2b39A:
undetectable
4kciB-2b39A:
undetectable		 4kciA-2b39A:
13.58
4kciB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCJ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4kcjA-2b39A:
undetectable
4kcjB-2b39A:
undetectable		 4kcjA-2b39A:
13.58
4kcjB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCJ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4kcjA-2b39A:
undetectable
4kcjB-2b39A:
undetectable		 4kcjA-2b39A:
13.58
4kcjB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCK_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4kckA-2b39A:
undetectable
4kckB-2b39A:
undetectable		 4kckA-2b39A:
13.58
4kckB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCK_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.11A 4kckA-2b39A:
undetectable
4kckB-2b39A:
undetectable		 4kckA-2b39A:
13.58
4kckB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCL_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4kclA-2b39A:
undetectable
4kclB-2b39A:
2.3		 4kclA-2b39A:
13.58
4kclB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCL_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4kclA-2b39A:
undetectable
4kclB-2b39A:
2.3		 4kclA-2b39A:
13.58
4kclB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCM_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4kcmA-2b39A:
undetectable
4kcmB-2b39A:
undetectable		 4kcmA-2b39A:
13.58
4kcmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCM_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4kcmA-2b39A:
undetectable
4kcmB-2b39A:
undetectable		 4kcmA-2b39A:
13.58
4kcmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4kcnA-2b39A:
undetectable
4kcnB-2b39A:
undetectable		 4kcnA-2b39A:
13.58
4kcnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4kcnA-2b39A:
undetectable
4kcnB-2b39A:
undetectable		 4kcnA-2b39A:
13.58
4kcnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCO_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4kcoA-2b39A:
undetectable
4kcoB-2b39A:
undetectable		 4kcoA-2b39A:
13.58
4kcoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCO_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4kcoA-2b39A:
undetectable
4kcoB-2b39A:
undetectable		 4kcoA-2b39A:
13.58
4kcoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KYA_A_FOLA703_0
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)		 2b39 C3
(Bos
taurus) 		5 / 11 ASP A1608
SER A1584
THR A1545
MET A1561
VAL A1626
 None
 1.41A 4kyaA-2b39A:
undetectable		 4kyaA-2b39A:
15.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4luxA-2b39A:
undetectable
4luxB-2b39A:
undetectable		 4luxA-2b39A:
13.58
4luxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 4luxA-2b39A:
undetectable
4luxB-2b39A:
undetectable		 4luxA-2b39A:
13.58
4luxB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LVC_A_ADNA501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 2b39 C3
(Bos
taurus) 		4 / 5 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.36A 4lvcA-2b39A:
undetectable		 4lvcA-2b39A:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LVC_C_ADNC501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 2b39 C3
(Bos
taurus) 		4 / 5 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.37A 4lvcC-2b39A:
undetectable		 4lvcC-2b39A:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MBS_A_MRVA1101_2
(CHIMERA PROTEIN OF
C-C CHEMOKINE
RECEPTOR TYPE 5 AND
RUBREDOXIN)		 2b39 C3
(Bos
taurus) 		4 / 7 GLN A  54
THR A  74
LEU A  44
THR A 646
 None
 1.02A 4mbsA-2b39A:
undetectable		 4mbsA-2b39A:
13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NOS_B_H4BB1011_1
(INDUCIBLE NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A1650
GLU A1652
ARG A1530
ILE A1567
 None
 1.48A 4nosA-2b39A:
undetectable
4nosB-2b39A:
undetectable		 4nosA-2b39A:
13.27
4nosB-2b39A:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_K_BO2K301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 2b39 C3
(Bos
taurus) 		5 / 9 ALA A 268
THR A 267
ILE A 255
GLY A 295
ALA A 256
 None
 1.19A 4qvqK-2b39A:
undetectable
4qvqL-2b39A:
undetectable		 4qvqK-2b39A:
8.98
4qvqL-2b39A:
9.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_Y_BO2Y301_1
(PROTEASOME SUBUNIT
BETA TYPE-5
PROTEASOME SUBUNIT
BETA TYPE-6)		 2b39 C3
(Bos
taurus) 		5 / 9 ALA A 268
THR A 267
ILE A 255
GLY A 295
ALA A 256
 None
 1.19A 4qvqY-2b39A:
undetectable
4qvqZ-2b39A:
undetectable		 4qvqY-2b39A:
8.98
4qvqZ-2b39A:
9.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCH_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 4uchA-2b39A:
undetectable
4uchB-2b39A:
undetectable		 4uchA-2b39A:
13.29
4uchB-2b39A:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCH_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 0.99A 4uchA-2b39A:
undetectable
4uchB-2b39A:
undetectable		 4uchA-2b39A:
13.29
4uchB-2b39A:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGZ_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.13A 4ugzA-2b39A:
undetectable
4ugzB-2b39A:
undetectable		 4ugzA-2b39A:
13.58
4ugzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGZ_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4ugzA-2b39A:
undetectable
4ugzB-2b39A:
undetectable		 4ugzA-2b39A:
13.58
4ugzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 4uh0A-2b39A:
undetectable
4uh0B-2b39A:
undetectable		 4uh0A-2b39A:
13.58
4uh0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.10A 4uh0A-2b39A:
undetectable
4uh0B-2b39A:
undetectable		 4uh0A-2b39A:
13.58
4uh0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH1_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4uh1A-2b39A:
undetectable
4uh1B-2b39A:
undetectable		 4uh1A-2b39A:
13.58
4uh1B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH1_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 4uh1A-2b39A:
undetectable
4uh1B-2b39A:
undetectable		 4uh1A-2b39A:
13.58
4uh1B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH2_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4uh2A-2b39A:
undetectable
4uh2B-2b39A:
undetectable		 4uh2A-2b39A:
13.58
4uh2B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 4uh2A-2b39A:
undetectable
4uh2B-2b39A:
undetectable		 4uh2A-2b39A:
13.58
4uh2B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4uh3A-2b39A:
undetectable
4uh3B-2b39A:
undetectable		 4uh3A-2b39A:
13.58
4uh3B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4uh3A-2b39A:
undetectable
4uh3B-2b39A:
undetectable		 4uh3A-2b39A:
13.58
4uh3B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4uh4A-2b39A:
undetectable
4uh4B-2b39A:
undetectable		 4uh4A-2b39A:
13.58
4uh4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4uh4A-2b39A:
undetectable
4uh4B-2b39A:
undetectable		 4uh4A-2b39A:
13.58
4uh4B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH5_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 4uh5A-2b39A:
undetectable
4uh5B-2b39A:
undetectable		 4uh5A-2b39A:
13.24
4uh5B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH5_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4uh5A-2b39A:
undetectable
4uh5B-2b39A:
undetectable		 4uh5A-2b39A:
13.24
4uh5B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4uh6A-2b39A:
undetectable
4uh6B-2b39A:
2.6		 4uh6A-2b39A:
13.24
4uh6B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4uh6A-2b39A:
undetectable
4uh6B-2b39A:
2.6		 4uh6A-2b39A:
13.24
4uh6B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPM_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4upmA-2b39A:
undetectable
4upmB-2b39A:
undetectable		 4upmA-2b39A:
13.58
4upmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPM_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4upmA-2b39A:
undetectable
4upmB-2b39A:
undetectable		 4upmA-2b39A:
13.58
4upmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 4upnA-2b39A:
undetectable
4upnB-2b39A:
2.1		 4upnA-2b39A:
13.58
4upnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4upnA-2b39A:
undetectable
4upnB-2b39A:
2.1		 4upnA-2b39A:
13.58
4upnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4upoA-2b39A:
undetectable
4upoB-2b39A:
undetectable		 4upoA-2b39A:
13.58
4upoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 4upoA-2b39A:
undetectable
4upoB-2b39A:
undetectable		 4upoA-2b39A:
13.58
4upoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 4uppA-2b39A:
undetectable
4uppB-2b39A:
undetectable		 4uppA-2b39A:
13.58
4uppB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 4uppA-2b39A:
undetectable
4uppB-2b39A:
undetectable		 4uppA-2b39A:
13.58
4uppB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3U_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.01A 4v3uA-2b39A:
undetectable
4v3uB-2b39A:
undetectable		 4v3uA-2b39A:
13.25
4v3uB-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3U_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 4v3uA-2b39A:
undetectable
4v3uB-2b39A:
undetectable		 4v3uA-2b39A:
13.25
4v3uB-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3U_C_H4BC760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 4v3uC-2b39A:
2.5
4v3uD-2b39A:
undetectable		 4v3uC-2b39A:
13.25
4v3uD-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3U_D_H4BD760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 0.99A 4v3uC-2b39A:
2.5
4v3uD-2b39A:
undetectable		 4v3uC-2b39A:
13.25
4v3uD-2b39A:
13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3V_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 4v3vA-2b39A:
undetectable
4v3vB-2b39A:
undetectable		 4v3vA-2b39A:
13.58
4v3vB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3V_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 4v3vA-2b39A:
undetectable
4v3vB-2b39A:
undetectable		 4v3vA-2b39A:
13.58
4v3vB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3W_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4v3wA-2b39A:
2.2
4v3wB-2b39A:
undetectable		 4v3wA-2b39A:
13.58
4v3wB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3X_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 4v3xA-2b39A:
undetectable
4v3xB-2b39A:
undetectable		 4v3xA-2b39A:
13.58
4v3xB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3X_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4v3xA-2b39A:
undetectable
4v3xB-2b39A:
undetectable		 4v3xA-2b39A:
13.58
4v3xB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3Y_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 4v3yA-2b39A:
undetectable
4v3yB-2b39A:
undetectable		 4v3yA-2b39A:
13.58
4v3yB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3Y_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 4v3yA-2b39A:
undetectable
4v3yB-2b39A:
undetectable		 4v3yA-2b39A:
13.58
4v3yB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3Z_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.03A 4v3zA-2b39A:
undetectable
4v3zB-2b39A:
undetectable		 4v3zA-2b39A:
13.58
4v3zB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3Z_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 4v3zA-2b39A:
undetectable
4v3zB-2b39A:
undetectable		 4v3zA-2b39A:
13.58
4v3zB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_B_RTZB602_2
(CYTOCHROME P450 2D6)		 2b39 C3
(Bos
taurus) 		3 / 3 GLU A1046
ILE A 166
ALA A1093
 None
 0.66A 4wnwB-2b39A:
undetectable		 4wnwB-2b39A:
15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUD_A_SAMA303_1
(CATECHOL
O-METHYLTRANSFERASE)		 2b39 C3
(Bos
taurus) 		3 / 3 SER A 797
GLU A 767
ASP A 597
 None
 0.85A 4xudA-2b39A:
undetectable		 4xudA-2b39A:
8.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5ad5A-2b39A:
undetectable
5ad5B-2b39A:
undetectable		 5ad5A-2b39A:
13.58
5ad5B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5ad5A-2b39A:
0.0
5ad5B-2b39A:
0.0		 5ad5A-2b39A:
13.58
5ad5B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5ad6A-2b39A:
undetectable
5ad6B-2b39A:
undetectable		 5ad6A-2b39A:
13.58
5ad6B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5ad6A-2b39A:
undetectable
5ad6B-2b39A:
undetectable		 5ad6A-2b39A:
13.58
5ad6B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD7_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5ad7A-2b39A:
undetectable
5ad7B-2b39A:
undetectable		 5ad7A-2b39A:
13.58
5ad7B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD9_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 5ad9A-2b39A:
undetectable
5ad9B-2b39A:
undetectable		 5ad9A-2b39A:
13.58
5ad9B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD9_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 5ad9A-2b39A:
undetectable
5ad9B-2b39A:
undetectable		 5ad9A-2b39A:
13.58
5ad9B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5adaA-2b39A:
undetectable
5adaB-2b39A:
undetectable		 5adaA-2b39A:
13.58
5adaB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5adaA-2b39A:
undetectable
5adaB-2b39A:
undetectable		 5adaA-2b39A:
13.58
5adaB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADB_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 5adbA-2b39A:
0.0
5adbB-2b39A:
0.0		 5adbA-2b39A:
13.58
5adbB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADC_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5adcA-2b39A:
undetectable
5adcB-2b39A:
undetectable		 5adcA-2b39A:
13.58
5adcB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADC_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 5adcA-2b39A:
undetectable
5adcB-2b39A:
undetectable		 5adcA-2b39A:
13.58
5adcB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADD_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5addA-2b39A:
undetectable
5addB-2b39A:
undetectable		 5addA-2b39A:
13.74
5addB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADE_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5adeA-2b39A:
undetectable
5adeB-2b39A:
undetectable		 5adeA-2b39A:
13.74
5adeB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADF_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5adfA-2b39A:
undetectable
5adfB-2b39A:
2.5		 5adfA-2b39A:
13.24
5adfB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5adgA-2b39A:
undetectable
5adgB-2b39A:
undetectable		 5adgA-2b39A:
13.24
5adgB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5adgA-2b39A:
undetectable
5adgB-2b39A:
undetectable		 5adgA-2b39A:
13.24
5adgB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADI_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5adiA-2b39A:
undetectable
5adiB-2b39A:
2.4		 5adiA-2b39A:
13.24
5adiB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGK_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5agkA-2b39A:
undetectable
5agkB-2b39A:
2.3		 5agkA-2b39A:
13.58
5agkB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 5agkA-2b39A:
undetectable
5agkB-2b39A:
2.3		 5agkA-2b39A:
13.58
5agkB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5aglA-2b39A:
undetectable
5aglB-2b39A:
undetectable		 5aglA-2b39A:
13.58
5aglB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGL_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 5aglA-2b39A:
undetectable
5aglB-2b39A:
undetectable		 5aglA-2b39A:
13.58
5aglB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5agmA-2b39A:
undetectable
5agmB-2b39A:
undetectable		 5agmA-2b39A:
13.58
5agmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 5agmA-2b39A:
undetectable
5agmB-2b39A:
undetectable		 5agmA-2b39A:
13.58
5agmB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 5agnA-2b39A:
undetectable
5agnB-2b39A:
undetectable		 5agnA-2b39A:
13.58
5agnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 5agnA-2b39A:
undetectable
5agnB-2b39A:
undetectable		 5agnA-2b39A:
13.58
5agnB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5agoA-2b39A:
undetectable
5agoB-2b39A:
undetectable		 5agoA-2b39A:
13.58
5agoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5agoA-2b39A:
undetectable
5agoB-2b39A:
undetectable		 5agoA-2b39A:
13.58
5agoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.12A 5agpA-2b39A:
undetectable
5agpB-2b39A:
undetectable		 5agpA-2b39A:
13.58
5agpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5agpA-2b39A:
undetectable
5agpB-2b39A:
undetectable		 5agpA-2b39A:
13.58
5agpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BMV_C_VLBC507_1
(TUBULIN BETA CHAIN
TUBULIN ALPHA-1B
CHAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 LYS A1083
TYR A1080
TYR A1065
LEU A1077
 None
 1.21A 5bmvB-2b39A:
undetectable		 5bmvB-2b39A:
13.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ESF_A_TPFA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 2b39 C3
(Bos
taurus) 		4 / 8 PHE A 221
ILE A 205
TYR A 146
THR A1053
 None
 0.89A 5esfA-2b39A:
undetectable		 5esfA-2b39A:
15.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5fvpA-2b39A:
0.0
5fvpB-2b39A:
0.0		 5fvpA-2b39A:
13.58
5fvpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 5fvpA-2b39A:
2.5
5fvpB-2b39A:
undetectable		 5fvpA-2b39A:
13.58
5fvpB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5fvqA-2b39A:
undetectable
5fvqB-2b39A:
undetectable		 5fvqA-2b39A:
13.58
5fvqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.10A 5fvqA-2b39A:
undetectable
5fvqB-2b39A:
undetectable		 5fvqA-2b39A:
13.58
5fvqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5fvrA-2b39A:
undetectable
5fvrB-2b39A:
undetectable		 5fvrA-2b39A:
13.58
5fvrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5fvrA-2b39A:
undetectable
5fvrB-2b39A:
undetectable		 5fvrA-2b39A:
13.58
5fvrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5fvsA-2b39A:
undetectable
5fvsB-2b39A:
undetectable		 5fvsA-2b39A:
13.58
5fvsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVS_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5fvsA-2b39A:
undetectable
5fvsB-2b39A:
undetectable		 5fvsA-2b39A:
13.58
5fvsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5fvtA-2b39A:
undetectable
5fvtB-2b39A:
undetectable		 5fvtA-2b39A:
13.58
5fvtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5fvtA-2b39A:
undetectable
5fvtB-2b39A:
undetectable		 5fvtA-2b39A:
13.58
5fvtB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5fvuA-2b39A:
undetectable
5fvuB-2b39A:
2.4		 5fvuA-2b39A:
13.24
5fvuB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 0.96A 5fvuA-2b39A:
undetectable
5fvuB-2b39A:
2.4		 5fvuA-2b39A:
13.24
5fvuB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5fvvA-2b39A:
undetectable
5fvvB-2b39A:
2.1		 5fvvA-2b39A:
13.24
5fvvB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 5fvvA-2b39A:
undetectable
5fvvB-2b39A:
undetectable		 5fvvA-2b39A:
13.24
5fvvB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 5fvwA-2b39A:
undetectable
5fvwB-2b39A:
2.1		 5fvwA-2b39A:
13.24
5fvwB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5fvwA-2b39A:
undetectable
5fvwB-2b39A:
2.0		 5fvwA-2b39A:
13.24
5fvwB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVX_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5fvxA-2b39A:
undetectable
5fvxB-2b39A:
2.6		 5fvxA-2b39A:
13.24
5fvxB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FW0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5fw0A-2b39A:
undetectable
5fw0B-2b39A:
undetectable		 5fw0A-2b39A:
13.58
5fw0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FW0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5fw0A-2b39A:
undetectable
5fw0B-2b39A:
undetectable		 5fw0A-2b39A:
13.58
5fw0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5g0nA-2b39A:
undetectable
5g0nB-2b39A:
undetectable		 5g0nA-2b39A:
13.64
5g0nB-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5g0nA-2b39A:
undetectable
5g0nB-2b39A:
undetectable		 5g0nA-2b39A:
13.64
5g0nB-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0O_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5g0oA-2b39A:
undetectable
5g0oB-2b39A:
undetectable		 5g0oA-2b39A:
13.64
5g0oB-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0O_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5g0oA-2b39A:
undetectable
5g0oB-2b39A:
undetectable		 5g0oA-2b39A:
13.64
5g0oB-2b39A:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 5g0pA-2b39A:
undetectable
5g0pB-2b39A:
undetectable		 5g0pA-2b39A:
13.74
5g0pB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5g0pA-2b39A:
undetectable
5g0pB-2b39A:
undetectable		 5g0pA-2b39A:
13.74
5g0pB-2b39A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IGP_A_ERYA402_0
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E)		 2b39 C3
(Bos
taurus) 		5 / 12 ALA A1194
ALA A1191
VAL A1188
LEU A1195
GLY A1172
 None
 1.31A 5igpA-2b39A:
undetectable		 5igpA-2b39A:
11.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J2T_C_VLBC503_1
(TUBULIN BETA-2B
CHAIN
TUBULIN ALPHA-1B
CHAIN)		 2b39 C3
(Bos
taurus) 		5 / 9 LYS A1083
VAL A1081
TYR A1080
TYR A1065
LEU A1077
 None
 1.36A 5j2tB-2b39A:
0.0		 5j2tB-2b39A:
14.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_A_1GNA608_1
(PHIAB6 TAILSPIKE)		 2b39 C3
(Bos
taurus) 		3 / 3 THR A1102
SER A1063
TYR A1065
 None
 0.88A 5jseA-2b39A:
undetectable		 5jseA-2b39A:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_B_1GNB611_1
(PHIAB6 TAILSPIKE)		 2b39 C3
(Bos
taurus) 		3 / 3 THR A1102
SER A1063
TYR A1065
 None
 0.88A 5jseB-2b39A:
undetectable		 5jseB-2b39A:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSE_C_1GNC611_1
(PHIAB6 TAILSPIKE)		 2b39 C3
(Bos
taurus) 		3 / 3 THR A1102
SER A1063
TYR A1065
 None
 0.89A 5jseC-2b39A:
undetectable		 5jseC-2b39A:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KC0_A_RBFA303_2
(RIBOFLAVIN
TRANSPORTER RIBU)		 2b39 C3
(Bos
taurus) 		3 / 3 LYS A1154
LEU A1087
ILE A1148
 None
 0.71A 5kc0A-2b39A:
undetectable		 5kc0A-2b39A:
7.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KC4_A_RBFA201_2
(RIBOFLAVIN
TRANSPORTER RIBU)		 2b39 C3
(Bos
taurus) 		3 / 3 LYS A1154
LEU A1087
ILE A1148
 None
 0.77A 5kc4A-2b39A:
undetectable		 5kc4A-2b39A:
7.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L94_A_TESA502_1
(CYTOCHROME P450)		 2b39 C3
(Bos
taurus) 		4 / 8 VAL A  59
ILE A  88
VAL A 120
VAL A 105
 None
 0.49A 5l94A-2b39A:
undetectable		 5l94A-2b39A:
13.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5K_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 2b39 C3
(Bos
taurus) 		4 / 4 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.37A 5m5kA-2b39A:
undetectable		 5m5kA-2b39A:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5K_C_ADNC502_2
(ADENOSYLHOMOCYSTEINA
SE)		 2b39 C3
(Bos
taurus) 		4 / 4 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.38A 5m5kC-2b39A:
undetectable		 5m5kC-2b39A:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M66_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 2b39 C3
(Bos
taurus) 		4 / 4 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.32A 5m66B-2b39A:
undetectable		 5m66B-2b39A:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OV9_A_CVIA608_0
(ACETYLCHOLINESTERASE)		 2b39 C3
(Bos
taurus) 		4 / 7 TYR A1065
THR A1102
LEU A1099
TYR A1052
 None
 1.10A 5ov9A-2b39A:
undetectable		 5ov9A-2b39A:
15.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGL_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2b39 C3
(Bos
taurus) 		3 / 3 VAL A 861
VAL A 915
GLN A 826
 None
 0.69A 5qglA-2b39A:
undetectable		 5qglA-2b39A:
7.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGU_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2b39 C3
(Bos
taurus) 		3 / 3 VAL A 861
VAL A 915
GLN A 826
 None
 0.71A 5qguA-2b39A:
undetectable		 5qguA-2b39A:
7.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHC_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2b39 C3
(Bos
taurus) 		3 / 3 VAL A 861
VAL A 915
GLN A 826
 None
 0.70A 5qhcA-2b39A:
undetectable		 5qhcA-2b39A:
7.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHE_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2b39 C3
(Bos
taurus) 		3 / 3 VAL A 861
VAL A 915
GLN A 826
 None
 0.71A 5qheA-2b39A:
undetectable		 5qheA-2b39A:
7.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHG_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2b39 C3
(Bos
taurus) 		3 / 3 VAL A 861
VAL A 915
GLN A 826
 None
 0.71A 5qhgA-2b39A:
undetectable		 5qhgA-2b39A:
7.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TE8_C_08JC602_1
(CYTOCHROME P450 3A4)		 2b39 C3
(Bos
taurus) 		4 / 7 LEU A1106
ALA A1149
ILE A1168
LEU A1164
 None
 0.82A 5te8C-2b39A:
undetectable		 5te8C-2b39A:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TRQ_B_ACTB307_0
(WELO5)		 2b39 C3
(Bos
taurus) 		3 / 3 GLU A 933
HIS A1348
VAL A 970
 None
 0.93A 5trqB-2b39A:
undetectable		 5trqB-2b39A:
11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TRQ_B_ACTB307_0
(WELO5)		 2b39 C3
(Bos
taurus) 		3 / 3 GLU A1137
HIS A1178
VAL A1140
 None
 0.92A 5trqB-2b39A:
undetectable		 5trqB-2b39A:
11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5unrA-2b39A:
undetectable
5unrB-2b39A:
undetectable		 5unrA-2b39A:
13.58
5unrB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5unsA-2b39A:
undetectable
5unsB-2b39A:
undetectable		 5unsA-2b39A:
13.58
5unsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNS_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5unsA-2b39A:
undetectable
5unsB-2b39A:
undetectable		 5unsA-2b39A:
13.58
5unsB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5untA-2b39A:
undetectable
5untB-2b39A:
undetectable		 5untA-2b39A:
13.58
5untB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5untA-2b39A:
undetectable
5untB-2b39A:
undetectable		 5untA-2b39A:
13.58
5untB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.14A 5unuA-2b39A:
undetectable
5unuB-2b39A:
undetectable		 5unuA-2b39A:
13.58
5unuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.12A 5unwA-2b39A:
2.6
5unwB-2b39A:
undetectable		 5unwA-2b39A:
13.58
5unwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5unwA-2b39A:
2.5
5unwB-2b39A:
undetectable		 5unwA-2b39A:
13.58
5unwB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 5unyA-2b39A:
undetectable
5unyB-2b39A:
undetectable		 5unyA-2b39A:
13.58
5unyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5unyA-2b39A:
undetectable
5unyB-2b39A:
undetectable		 5unyA-2b39A:
13.58
5unyB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.11A 5unzA-2b39A:
undetectable
5unzB-2b39A:
undetectable		 5unzA-2b39A:
13.58
5unzB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO0_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5uo0A-2b39A:
2.5
5uo0B-2b39A:
undetectable		 5uo0A-2b39A:
13.58
5uo0B-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5uo1A-2b39A:
undetectable
5uo1B-2b39A:
undetectable		 5uo1A-2b39A:
13.24
5uo1B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5uo1A-2b39A:
undetectable
5uo1B-2b39A:
undetectable		 5uo1A-2b39A:
13.24
5uo1B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO2_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 5uo2A-2b39A:
undetectable
5uo2B-2b39A:
2.6		 5uo2A-2b39A:
13.24
5uo2B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO2_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5uo2A-2b39A:
undetectable
5uo2B-2b39A:
2.6		 5uo2A-2b39A:
13.24
5uo2B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5uo3A-2b39A:
undetectable
5uo3B-2b39A:
undetectable		 5uo3A-2b39A:
13.24
5uo3B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.13A 5uo3A-2b39A:
undetectable
5uo3B-2b39A:
undetectable		 5uo3A-2b39A:
13.24
5uo3B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO4_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 5uo4A-2b39A:
undetectable
5uo4B-2b39A:
undetectable		 5uo4A-2b39A:
13.24
5uo4B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 5uo4A-2b39A:
undetectable
5uo4B-2b39A:
undetectable		 5uo4A-2b39A:
13.24
5uo4B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5uo5A-2b39A:
undetectable
5uo5B-2b39A:
undetectable		 5uo5A-2b39A:
13.24
5uo5B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5uo5A-2b39A:
undetectable
5uo5B-2b39A:
undetectable		 5uo5A-2b39A:
13.24
5uo5B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO6_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5uo6A-2b39A:
undetectable
5uo6B-2b39A:
undetectable		 5uo6A-2b39A:
13.24
5uo6B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 8 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5uo7A-2b39A:
undetectable
5uo7B-2b39A:
undetectable		 5uo7A-2b39A:
13.24
5uo7B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 5uo7A-2b39A:
undetectable
5uo7B-2b39A:
undetectable		 5uo7A-2b39A:
13.24
5uo7B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UUN_A_ACTA312_0
(GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN)		 2b39 C3
(Bos
taurus) 		3 / 3 ILE A 760
VAL A 227
PRO A 229
 None
 0.60A 5uunA-2b39A:
3.6		 5uunA-2b39A:
10.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VEU_A_RITA602_2
(CYTOCHROME P450 3A5)		 2b39 C3
(Bos
taurus) 		3 / 3 ARG A1253
PHE A1275
LEU A1236
 None
 0.68A 5veuA-2b39A:
undetectable		 5veuA-2b39A:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5vuiA-2b39A:
2.5
5vuiB-2b39A:
undetectable		 5vuiA-2b39A:
13.58
5vuiB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5vuiA-2b39A:
2.5
5vuiB-2b39A:
undetectable		 5vuiA-2b39A:
13.58
5vuiB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUJ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.20A 5vujA-2b39A:
undetectable
5vujB-2b39A:
undetectable		 5vujA-2b39A:
13.58
5vujB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUJ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.13A 5vujA-2b39A:
undetectable
5vujB-2b39A:
undetectable		 5vujA-2b39A:
13.58
5vujB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUK_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5vukA-2b39A:
undetectable
5vukB-2b39A:
undetectable		 5vukA-2b39A:
13.58
5vukB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUK_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5vukA-2b39A:
undetectable
5vukB-2b39A:
undetectable		 5vukA-2b39A:
13.58
5vukB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUL_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5vulA-2b39A:
undetectable
5vulB-2b39A:
undetectable		 5vulA-2b39A:
13.58
5vulB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUL_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5vulA-2b39A:
undetectable
5vulB-2b39A:
undetectable		 5vulA-2b39A:
13.58
5vulB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUM_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5vumA-2b39A:
undetectable
5vumB-2b39A:
undetectable		 5vumA-2b39A:
13.58
5vumB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUM_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5vumA-2b39A:
undetectable
5vumB-2b39A:
undetectable		 5vumA-2b39A:
13.58
5vumB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUN_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5vunA-2b39A:
undetectable
5vunB-2b39A:
undetectable		 5vunA-2b39A:
13.58
5vunB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUN_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5vunA-2b39A:
undetectable
5vunB-2b39A:
undetectable		 5vunA-2b39A:
13.58
5vunB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUO_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5vuoA-2b39A:
2.4
5vuoB-2b39A:
undetectable		 5vuoA-2b39A:
13.58
5vuoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUO_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5vuoA-2b39A:
2.4
5vuoB-2b39A:
undetectable		 5vuoA-2b39A:
13.58
5vuoB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUP_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5vupA-2b39A:
undetectable
5vupB-2b39A:
undetectable		 5vupA-2b39A:
13.58
5vupB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUP_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5vupA-2b39A:
undetectable
5vupB-2b39A:
undetectable		 5vupA-2b39A:
13.58
5vupB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUQ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5vuqA-2b39A:
undetectable
5vuqB-2b39A:
undetectable		 5vuqA-2b39A:
13.58
5vuqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUQ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5vuqA-2b39A:
undetectable
5vuqB-2b39A:
undetectable		 5vuqA-2b39A:
13.58
5vuqB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 5vurA-2b39A:
undetectable
5vurB-2b39A:
2.2		 5vurA-2b39A:
13.58
5vurB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5vusA-2b39A:
2.5
5vusB-2b39A:
undetectable		 5vusA-2b39A:
13.58
5vusB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5vusA-2b39A:
2.5
5vusB-2b39A:
undetectable		 5vusA-2b39A:
13.58
5vusB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5vutA-2b39A:
undetectable
5vutB-2b39A:
undetectable		 5vutA-2b39A:
13.58
5vutB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5vutA-2b39A:
undetectable
5vutB-2b39A:
undetectable		 5vutA-2b39A:
13.58
5vutB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5vuuA-2b39A:
undetectable
5vuuB-2b39A:
undetectable		 5vuuA-2b39A:
13.58
5vuuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 5vuuA-2b39A:
undetectable
5vuuB-2b39A:
undetectable		 5vuuA-2b39A:
13.58
5vuuB-2b39A:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5vuvA-2b39A:
2.4
5vuvB-2b39A:
undetectable		 5vuvA-2b39A:
13.24
5vuvB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 5vuvA-2b39A:
2.4
5vuvB-2b39A:
undetectable		 5vuvA-2b39A:
13.24
5vuvB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5vuwA-2b39A:
undetectable
5vuwB-2b39A:
undetectable		 5vuwA-2b39A:
13.24
5vuwB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5vuwA-2b39A:
undetectable
5vuwB-2b39A:
undetectable		 5vuwA-2b39A:
13.24
5vuwB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 5vuxA-2b39A:
undetectable
5vuxB-2b39A:
undetectable		 5vuxA-2b39A:
13.24
5vuxB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 5vuyA-2b39A:
2.4
5vuyB-2b39A:
undetectable		 5vuyA-2b39A:
13.24
5vuyB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 5vuyA-2b39A:
2.3
5vuyB-2b39A:
undetectable		 5vuyA-2b39A:
13.24
5vuyB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5vuzA-2b39A:
undetectable
5vuzB-2b39A:
undetectable		 5vuzA-2b39A:
13.24
5vuzB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 5vuzA-2b39A:
undetectable
5vuzB-2b39A:
undetectable		 5vuzA-2b39A:
13.24
5vuzB-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV0_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 5vv0A-2b39A:
2.4
5vv0B-2b39A:
2.5		 5vv0A-2b39A:
13.24
5vv0B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV0_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 5vv0A-2b39A:
2.4
5vv0B-2b39A:
2.5		 5vv0A-2b39A:
13.24
5vv0B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5vv1A-2b39A:
undetectable
5vv1B-2b39A:
2.5		 5vv1A-2b39A:
13.24
5vv1B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 5vv1A-2b39A:
undetectable
5vv1B-2b39A:
2.5		 5vv1A-2b39A:
13.24
5vv1B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV2_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5vv2A-2b39A:
undetectable
5vv2B-2b39A:
2.5		 5vv2A-2b39A:
13.24
5vv2B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV2_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5vv2A-2b39A:
undetectable
5vv2B-2b39A:
2.5		 5vv2A-2b39A:
13.24
5vv2B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 5vv3A-2b39A:
2.4
5vv3B-2b39A:
undetectable		 5vv3A-2b39A:
13.24
5vv3B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 5vv3A-2b39A:
2.4
5vv3B-2b39A:
undetectable		 5vv3A-2b39A:
13.24
5vv3B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 5vv4A-2b39A:
undetectable
5vv4B-2b39A:
2.5		 5vv4A-2b39A:
13.24
5vv4B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 5vv5A-2b39A:
undetectable
5vv5B-2b39A:
2.3		 5vv5A-2b39A:
13.24
5vv5B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 5vv5A-2b39A:
undetectable
5vv5B-2b39A:
2.3		 5vv5A-2b39A:
13.24
5vv5B-2b39A:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W3J_B_TA1B502_1
(TUBULIN BETA CHAIN)		 2b39 C3
(Bos
taurus) 		5 / 8 VAL A 544
GLU A 543
HIS A  47
GLN A 541
GLY A 540
 None
 1.44A 5w3jB-2b39A:
undetectable		 5w3jB-2b39A:
14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W97_J_CHDJ101_1
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.19A 5w97J-2b39A:
undetectable		 5w97J-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WAU_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 4 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.17A 5wauj-2b39A:
0.0		 5wauj-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WAU_J_CHDJ101_1
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.23A 5wauJ-2b39A:
undetectable		 5wauJ-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X19_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.33A 5x19J-2b39A:
undetectable		 5x19J-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X19_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 4 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.41A 5x19W-2b39A:
0.0		 5x19W-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.35A 5x1bJ-2b39A:
undetectable		 5x1bJ-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.06A 5x1bW-2b39A:
undetectable		 5x1bW-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.15A 5x1fW-2b39A:
undetectable		 5x1fW-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDQ_C_CHDC308_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 PHE A 363
PHE A 369
LEU A 371
PHE A 356
 None
 1.31A 5xdqC-2b39A:
undetectable
5xdqJ-2b39A:
undetectable		 5xdqC-2b39A:
9.83
5xdqJ-2b39A:
3.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUQ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 6 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.11A 6auqA-2b39A:
undetectable
6auqB-2b39A:
undetectable		 6auqA-2b39A:
4.04
6auqB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUQ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 6auqA-2b39A:
undetectable
6auqB-2b39A:
undetectable		 6auqA-2b39A:
4.04
6auqB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUR_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 6aurA-2b39A:
undetectable
6aurB-2b39A:
undetectable		 6aurA-2b39A:
4.04
6aurB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 6aurA-2b39A:
undetectable
6aurB-2b39A:
undetectable		 6aurA-2b39A:
4.04
6aurB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 6ausA-2b39A:
undetectable
6ausB-2b39A:
undetectable		 6ausA-2b39A:
4.04
6ausB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUS_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 6ausA-2b39A:
undetectable
6ausB-2b39A:
undetectable		 6ausA-2b39A:
4.04
6ausB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.09A 6autA-2b39A:
undetectable
6autB-2b39A:
undetectable		 6autA-2b39A:
4.04
6autB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 6autA-2b39A:
undetectable
6autB-2b39A:
undetectable		 6autA-2b39A:
4.04
6autB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 6auuA-2b39A:
2.5
6auuB-2b39A:
undetectable		 6auuA-2b39A:
4.04
6auuB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.03A 6auuA-2b39A:
2.5
6auuB-2b39A:
undetectable		 6auuA-2b39A:
4.04
6auuB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUV_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 6auvA-2b39A:
undetectable
6auvB-2b39A:
undetectable		 6auvA-2b39A:
4.04
6auvB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 6auvA-2b39A:
undetectable
6auvB-2b39A:
undetectable		 6auvA-2b39A:
4.04
6auvB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.10A 6auwA-2b39A:
undetectable
6auwB-2b39A:
undetectable		 6auwA-2b39A:
4.04
6auwB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.07A 6auwA-2b39A:
undetectable
6auwB-2b39A:
undetectable		 6auwA-2b39A:
4.04
6auwB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 6auxA-2b39A:
undetectable
6auxB-2b39A:
undetectable		 6auxA-2b39A:
4.04
6auxB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 6auxA-2b39A:
undetectable
6auxB-2b39A:
undetectable		 6auxA-2b39A:
4.04
6auxB-2b39A:
4.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 6auyA-2b39A:
undetectable
6auyB-2b39A:
2.5		 6auyA-2b39A:
3.67
6auyB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 6auyA-2b39A:
undetectable
6auyB-2b39A:
2.5		 6auyA-2b39A:
3.67
6auyB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 6auzA-2b39A:
undetectable
6auzB-2b39A:
2.1		 6auzA-2b39A:
3.67
6auzB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 6auzA-2b39A:
undetectable
6auzB-2b39A:
2.1		 6auzA-2b39A:
3.67
6auzB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV0_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 6av0A-2b39A:
undetectable
6av0B-2b39A:
2.5		 6av0A-2b39A:
3.67
6av0B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV0_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.05A 6av0A-2b39A:
undetectable
6av0B-2b39A:
2.5		 6av0A-2b39A:
3.67
6av0B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.12A 6av1A-2b39A:
undetectable
6av1B-2b39A:
undetectable		 6av1A-2b39A:
3.67
6av1B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.02A 6av1A-2b39A:
undetectable
6av1B-2b39A:
undetectable		 6av1A-2b39A:
3.67
6av1B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV2_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 6av2A-2b39A:
undetectable
6av2B-2b39A:
undetectable		 6av2A-2b39A:
3.67
6av2B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV2_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.04A 6av2A-2b39A:
undetectable
6av2B-2b39A:
undetectable		 6av2A-2b39A:
3.67
6av2B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 6av3A-2b39A:
undetectable
6av3B-2b39A:
2.4		 6av3A-2b39A:
3.67
6av3B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.06A 6av3A-2b39A:
undetectable
6av3B-2b39A:
2.4		 6av3A-2b39A:
3.67
6av3B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV4_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.05A 6av4A-2b39A:
undetectable
6av4B-2b39A:
undetectable		 6av4A-2b39A:
3.67
6av4B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 6av4A-2b39A:
undetectable
6av4B-2b39A:
undetectable		 6av4A-2b39A:
3.67
6av4B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.08A 6av5A-2b39A:
undetectable
6av5B-2b39A:
undetectable		 6av5A-2b39A:
3.67
6av5B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV5_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 6av5A-2b39A:
undetectable
6av5B-2b39A:
undetectable		 6av5A-2b39A:
3.67
6av5B-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C2M_B_SUEB1202_1
(NS3 PROTEASE)		 2b39 C3
(Bos
taurus) 		5 / 9 VAL A1306
LEU A 946
ARG A1307
ALA A1333
ASP A1294
 None
 1.24A 6c2mB-2b39A:
undetectable		 6c2mB-2b39A:
4.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.06A 6cicA-2b39A:
undetectable
6cicB-2b39A:
undetectable		 6cicA-2b39A:
3.67
6cicB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_B_H4BB802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.08A 6cicA-2b39A:
undetectable
6cicB-2b39A:
undetectable		 6cicA-2b39A:
3.67
6cicB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 ARG A 708
VAL A1424
PHE A 722
GLU A 693
 None
 1.07A 6cidA-2b39A:
2.4
6cidB-2b39A:
2.4		 6cidA-2b39A:
3.67
6cidB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_B_H4BB803_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2b39 C3
(Bos
taurus) 		4 / 7 PHE A 722
GLU A 693
ARG A 708
VAL A1424
 None
 1.09A 6cidA-2b39A:
2.4
6cidB-2b39A:
2.4		 6cidA-2b39A:
3.67
6cidB-2b39A:
3.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 2b39 C3
(Bos
taurus) 		3 / 3 LEU A 197
GLY A1051
PHE A1272
 None
 0.62A 6exiC-2b39A:
undetectable		 6exiC-2b39A:
4.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F3M_B_ADNB502_2
(-)		 2b39 C3
(Bos
taurus) 		4 / 4 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.35A 6f3mB-2b39A:
undetectable		 6f3mB-2b39A:
14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F7L_B_ACTB503_0
(AMINE OXIDASE LKCE)		 2b39 C3
(Bos
taurus) 		3 / 3 VAL A 553
GLU A 462
ILE A 519
 None
 0.65A 6f7lB-2b39A:
undetectable		 6f7lB-2b39A:
13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GBN_A_ADNA501_2
(-)		 2b39 C3
(Bos
taurus) 		4 / 5 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.39A 6gbnA-2b39A:
undetectable		 6gbnA-2b39A:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GBN_D_ADND501_2
(-)		 2b39 C3
(Bos
taurus) 		4 / 5 GLN A1126
THR A1398
THR A1268
LEU A1483
 None
 1.39A 6gbnD-2b39A:
undetectable		 6gbnD-2b39A:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MKE_D_FK5D201_0
(PEPTIDYLPROLYL
ISOMERASE)		 2b39 C3
(Bos
taurus) 		4 / 4 ASP A 827
ILE A 887
PRO A 888
LEU A 859
 None
 1.32A 6mkeA-2b39A:
undetectable		 6mkeA-2b39A:
4.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2b39 C3
(Bos
taurus) 		4 / 5 TYR A1179
ARG A1205
THR A1207
LEU A1210
 None
 1.07A 6nknJ-2b39A:
undetectable		 6nknJ-2b39A:
3.49